| 05 2013 |
| |
| Product No. |
CAS |
Description |
| H27078 |
534-00-9 |
1-Bromo-2-methylbutane, 95%, mixture of enantiomers, predominantly (S)-, stab. |
| 47030 |
12045-64-6 |
Zirconium boride, 99.5% (metals basis excluding Hf) |
| 13862 |
|
Phosphorus, plasma standard solution, Specpure®, P 1000µg/ml |
| J65347 |
134448-10-5 |
Cathepsin B Inhibitor III |
| |
| |
| 04 2013 |
| |
| Product No. |
CAS |
Description |
| H62319 |
1222709-29-6 |
trans-1-Acetyl-3-(Boc-amino)cyclohexane, 97% |
| H62154 |
159766-56-0 |
Nepsilon-Acetyl-Nalpha-Fmoc-L-lysine, 98% |
| H62529 |
920966-29-6 |
trans-3-Aminocyclohexanecarboxamide hydrochloride, 97% |
| H62232 |
862401-49-8 |
trans-3-Aminocyclohexanecarboxylic acid hydrochloride, 97% |
| H62325 |
1222709-27-4 |
trans-3-Aminomethyl-1-(Boc-amino)cyclohexane, 97% |
| H62732 |
1027338-34-6 |
1-Aminomethyl-1-(Boc-amino)cyclopropane, 97% |
| H61368 |
18494-87-6 |
Benzo[b]thiophene-3-sulfonyl chloride, 97% |
| H62122 |
190004-53-6 |
1-(Benzyloxycarbonylamino)cyclobutanecarboxylic acid, 97% |
| H62329 |
685508-28-5 |
cis-2-(Benzyloxycarbonylamino)cyclobutanecarboxylic acid, 97% |
| H62919 |
1212272-03-1 |
trans-2-(Benzyloxycarbonylamino)cyclobutanecarboxylic acid, 97% |
| H62546 |
917022-26-5 |
cis-4-(Benzyloxycarbonylamino)cyclohexanecarboxaldehyde, 97% |
| H62957 |
412357-50-7 |
trans-4-(Benzyloxycarbonylamino)cyclohexanecarboxaldehyde, 97% |
| H62109 |
67299-52-9 |
cis-4-(Benzyloxycarbonylamino)cyclohexanecarboxylic acid, 97% |
| H62926 |
34771-04-5 |
trans-4-(Benzyloxycarbonylamino)cyclohexanecarboxylic acid, 97% |
| H62094 |
|
cis-3-(Benzyloxycarbonylamino)cyclohexanemethanol, 97% |
| H62842 |
1202411-95-7 |
trans-3-(Benzyloxycarbonylamino)cyclohexanemethanol, 97% |
| H62799 |
124678-01-9 |
cis-6-Benzyloxycarbonylamino-3-cyclohexene-1-methanol, 97% |
| H62409 |
1222709-28-5 |
trans-3-(Benzyloxycarbonylamino)cyclohexylamine hydrochloride, 97% |
| H62500 |
149423-70-1 |
cis-4-(Benzyloxycarbonylamino)cyclohexylamine, 97% |
| H62444 |
149423-77-8 |
trans-4-(Benzyloxycarbonylamino)cyclohexylamine, 97% |
| H62034 |
177582-74-0 |
trans-4-(Benzyloxycarbonylaminomethyl)cyclohexanemethylamine, 97% |
| H62693 |
187533-10-4 |
trans-4-(Benzyloxycarbonylaminomethyl)cyclohexanemethylamine hydrochloride, 97% |
| H62647 |
1355152-76-9 |
trans-3-(Benzyloxycarbonylaminomethyl)cyclohexylamine oxalate, 97% |
| H62306 |
4779-31-1 |
N-Benzyloxycarbonyl-L-aspartic acid 1-benzyl ester, 95% |
| H62579 |
172324-68-4 |
cis-3-(Benzyloxymethyl)cyclobutanol, 97% |
| H62088 |
172324-65-1 |
trans-3-(Benzyloxymethyl)cyclobutanol, 97% |
| H62159 |
172324-67-3 |
3-(Benzyloxymethyl)cyclobutanone, 97% |
| H61555 |
31970-04-4 |
Benzyl 3-pyrroline-1-carboxylate, 90% |
| H61243 |
|
N-[3,5-Bis(trifluoromethyl)phenyl]-4-bromo-5-fluorobenzenesulfonamide, 97% |
| H62670 |
1212405-03-2 |
trans-1-(Boc-amino)-3-(bromomethyl)cyclohexane, 97% |
| H62469 |
1222709-30-9 |
trans-1-(Boc-amino)-4-(bromomethyl)cyclohexane, 97% |
| H62171 |
1198163-56-2 |
cis-1-(Boc-amino)-3-cyanocyclohexane, 97% |
| H62850 |
920966-19-4 |
trans-1-(Boc-amino)-3-cyanocyclohexane, 97% |
| H62060 |
873537-32-7 |
trans-1-(Boc-amino)-4-cyanocyclohexane, 97% |
| H62667 |
1008773-79-2 |
cis-3-(Boc-amino)cyclobutanecarboxylic acid, 97% |
| H62902 |
939400-34-7 |
trans-3-(Boc-amino)cyclobutanecarboxylic acid, 97% |
| H62686 |
142733-64-0 |
cis-3-(Boc-amino)cyclobutanemethanol, 97% |
| H62719 |
167081-37-0 |
trans-3-(Boc-amino)cyclobutanemethanol, 97% |
| H62099 |
847417-37-2 |
cis-4-(Boc-amino)cyclohexaneacetaldehyde, 97% |
| H62373 |
215790-29-7 |
trans-4-(Boc-amino)cyclohexaneacetaldehyde, 97% |
| H62722 |
327156-95-6 |
cis-4-(Boc-amino)cyclohexaneacetic acid, 97% |
| H62058 |
189153-10-4 |
trans-4-(Boc-amino)cyclohexaneacetic acid, 97% |
| H62871 |
181308-56-5 |
cis-4-(Boc-amino)cyclohexanecarboxaldehyde, 97% |
| H62338 |
181308-57-6 |
trans-4-(Boc-amino)cyclohexanecarboxaldehyde, 97% |
| H62281 |
222530-33-8 |
cis-3-(Boc-amino)cyclohexanecarboxylic acid, 97% |
| H62207 |
218772-92-0 |
trans-3-(Boc-amino)cyclohexanecarboxylic acid, 97% |
| H62744 |
920966-16-1 |
cis-3-(Boc-amino)cyclohexanemethanol, 97% |
| H62934 |
920966-17-2 |
trans-3-(Boc-amino)cyclohexanemethanol, 97% |
| H62187 |
509143-00-4 |
cis-4-(Boc-amino)cyclohexanemethylamine, 97% |
| H62062 |
177583-27-6 |
trans-4-(Boc-amino)cyclohexanemethylamine, 97% |
| H62238 |
167081-25-6 |
cis-4-(Boc-amino)cyclohexanol, 97% |
| H62802 |
111300-06-2 |
trans-4-(Boc-amino)cyclohexanol, 97% |
| H62925 |
247570-24-7 |
cis-4-(Boc-amino)cyclohexylamine, 97% |
| H62734 |
177906-48-8 |
trans-4-(Boc-amino)cyclohexylamine, 97% |
| H62917 |
509143-12-8 |
2-[cis-4-(Boc-amino)cyclohexyl]ethylamine, 97% |
| H62326 |
1212272-05-3 |
2-[trans-4-(Boc-amino)cyclohexyl]ethylamine, 97% |
| H62220 |
1021853-63-3 |
cis-3-[4-(Boc-amino)cyclohexyl]propionic acid, 97% |
| H62844 |
204245-65-8 |
trans-3-[4-(Boc-amino)cyclohexyl]propionic acid, 97% |
| H62795 |
170299-61-3 |
cis-2-(Boc-amino)cyclopropanemethanol, 97% |
| H62222 |
170299-53-3 |
trans-2-(Boc-amino)cyclopropanemethanol, 97% |
| H62905 |
947141-86-8 |
trans-1-(Boc-amino)-4-ethynylcyclohexane, 97% |
| H62557 |
1069120-19-9 |
cis-1-(Boc-amino)-4-(2-hydroxyethyl)cyclohexane, 97% |
| H62087 |
917342-29-1 |
trans-1-(Boc-amino)-4-(2-hydroxyethyl)cyclohexane, 97% |
| H62730 |
1212331-06-0 |
trans-1-(Boc-amino)-3-(N-methoxy-N-methylcarbamoyl)cyclohexane, 97% |
| H62397 |
400898-92-2 |
trans-1-(Boc-amino)-4-(N-methoxy-N-methylcarbamoyl)cyclohexane, 97% |
| H62156 |
162046-58-4 |
trans-4-(Boc-aminomethyl)cyclohexanecarboxylic acid, 97% |
| H62798 |
172348-63-9 |
trans-4-(Boc-aminomethyl)cyclohexanemethanol, 97% |
| H62906 |
166168-16-7 |
trans-4-(Boc-aminomethyl)cyclohexanemethylamine, 97% |
| H62564 |
192323-07-2 |
trans-4-(Boc-aminomethyl)cyclohexylamine, 97% |
| H62078 |
1198355-16-6 |
trans-1-(Boc-amino)-4-vinylcyclohexane, 97% |
| H62038 |
205445-56-3 |
N-Boc-3-cyano-D-phenylalanine, 95% |
| H63351 |
95715-87-0 |
(R)-(+)-3-Boc-2,2-dimethyloxazolidine-4-carboxaldehyde, 95% |
| H62367 |
114873-10-8 |
N-Boc-2-fluoro-D-phenylalanine, 95% |
| H62620 |
114873-00-6 |
N-Boc-2-fluoro-L-phenylalanine, 98% |
| H62688 |
1212165-74-6 |
trans-N-Boc-4-[2-(Fmoc-amino)ethyl]cyclohexylamine, 97% |
| H62116 |
115186-31-7 |
Nalpha-Boc-Nepsilon-Fmoc-D-lysine, 95% |
| H55966 |
174855-57-3 |
1-Boc-4-(2-formylphenyl)piperazine, 97% |
| H55413 |
197638-83-8 |
1-Boc-4-(4-formylphenyl)piperazine, 97% |
| H62537 |
35793-73-8 |
N-Boc-D-glutamic acid 5-benzyl ester, 98% |
| H62612 |
114873-14-2 |
N-Boc-3-methyl-D-phenylalanine, 95% |
| H61814 |
76932-48-4 |
N-Boc-3-(1-naphthyl)-D-alanine, 98% |
| H62896 |
147923-08-8 |
N-Boc-4-phenyl-L-phenylalanine, 95% |
| H62446 |
132388-68-2 |
Nalpha-Boc-Ngamma-trityl-L-asparagine, 98% |
| H62112 |
132388-69-3 |
Nalpha-Boc-Ndelta-trityl-L-glutamine, 98% |
| H61210 |
|
N-(4-Bromobenzyl)-2,5-difluorobenzamide, 97% |
| H61635 |
|
4-Bromo-N-(4-bromobenzyl)-5-fluorobenzenesulfonamide, 97% |
| H61726 |
|
4-Bromo-N-(4-bromo-3-fluorophenyl)-5-fluorobenzenesulfonamide, 97% |
| H61714 |
|
4-Bromo-N-(4-n-butylphenyl)-5-fluorobenzenesulfonamide, 97% |
| H61901 |
|
4-Bromo-N-(3-chloro-4-methoxyphenyl)-5-fluorobenzenesulfonamide, 97% |
| H61709 |
|
4-Bromo-N-(5-chloro-2-methoxyphenyl)-5-fluorobenzenesulfonamide, 97% |
| H61034 |
|
N-(4-Bromo-2-chlorophenyl)-2,5-difluorobenzamide, 97% |
| H61168 |
|
N-(4-Bromo-2-chlorophenyl)-3,5-difluorobenzamide, 97% |
| H61463 |
|
4-Bromo-N-[2-chloro-4-(trifluoromethyl)phenyl]-5-fluorobenzenesulfonamide, 97% |
| H61797 |
|
4-Bromo-N-[2-chloro-5-(trifluoromethyl)phenyl]-5-fluorobenzenesulfonamide, 97% |
| H61874 |
|
4-Bromo-N-[4-chloro-2-(trifluoromethyl)phenyl]-5-fluorobenzenesulfonamide, 97% |
| H61362 |
|
4-Bromo-N-[4-chloro-3-(trifluoromethyl)phenyl]-5-fluorobenzenesulfonamide, 97% |
| H61349 |
|
4-Bromo-N-(2,4-dibromophenyl)-5-fluorobenzenesulfonamide, 97% |
| H61295 |
|
4-Bromo-N-(2-ethoxyphenyl)-5-fluorobenzenesulfonamide, 97% |
| H61418 |
|
4-Bromo-N-(4-ethoxyphenyl)-5-fluorobenzenesulfonamide, 97% |
| H61566 |
|
4-Bromo-N-(2-ethylphenyl)-5-fluorobenzenesulfonamide, 97% |
| H61667 |
|
4-Bromo-N-(4-ethylphenyl)-5-fluorobenzenesulfonamide, 97% |
| H61261 |
1006-33-3 |
2'-Bromo-5'-fluoroacetophenone, 98% |
| H61165 |
|
4-Bromo-5-fluoro-N-(2-fluoro-4-methylphenyl)benzenesulfonamide, 97% |
| H61653 |
|
4-Bromo-5-fluoro-N-[2-fluoro-5-(trifluoromethyl)phenyl]benzenesulfonamide, 97% |
| H61799 |
|
4-Bromo-5-fluoro-N-[4-fluoro-2-(trifluoromethyl)phenyl]benzenesulfonamide, 97% |
| H61857 |
|
4-Bromo-5-fluoro-N-[4-fluoro-3-(trifluoromethyl)phenyl]benzenesulfonamide, 97% |
| H61657 |
|
4-Bromo-5-fluoro-N-(2-isopropylphenyl)benzenesulfonamide, 97% |
| H61696 |
|
4-Bromo-5-fluoro-N-(3-isopropylphenyl)benzenesulfonamide, 97% |
| H61854 |
|
4-Bromo-5-fluoro-N-(4-isopropylphenyl)benzenesulfonamide, 97% |
| H61734 |
|
4-Bromo-5-fluoro-N-(2-methoxybenzyl)benzenesulfonamide, 97% |
| H61305 |
|
4-Bromo-5-fluoro-N-(2-methoxyphenyl)benzenesulfonamide, 97% |
| H61460 |
|
4-Bromo-5-fluoro-N-(3-methoxyphenyl)benzenesulfonamide, 97% |
| H61661 |
|
4-Bromo-5-fluoro-N-(4-methoxyphenyl)benzenesulfonamide, 97% |
| H61027 |
|
N-(2-Bromo-4-fluorophenyl)-2,5-difluorobenzamide, 97% |
| H61091 |
|
N-(4-Bromo-2-fluorophenyl)-2,5-difluorobenzamide, 97% |
| H61499 |
|
N-(4-Bromo-2-fluorophenyl)-3,5-difluorobenzamide, 97% |
| H61195 |
|
4-Bromo-5-fluoro-N-(2,3,4-trifluorophenyl)benzenesulfonamide, 97% |
| H61074 |
|
N-(2-Bromo-4-methylphenyl)-2,5-difluorobenzamide, 97% |
| H61974 |
|
N-(2-Bromo-4-methylphenyl)-3,5-difluorobenzamide, 97% |
| H61007 |
|
N-(3-Bromo-4-methylphenyl)-2,5-difluorobenzamide, 97% |
| H61187 |
|
N-(4-Bromo-2-methylphenyl)-3,5-difluorobenzamide, 97% |
| H61755 |
|
N-(4-Bromo-3-methylphenyl)-3,5-difluorobenzamide, 97% |
| H61038 |
|
N-(4-Bromo-3-methylphenyl)-2,5-difluorobenzamide, 97% |
| H37778 |
89972-76-9 |
4'-(4-Bromophenyl)-2,6':2',2''-terpyridine, 98% |
| H61375 |
122306-01-8 |
2-Bromo-5-pyridinemethanol, 95% |
| H61967 |
36856-91-4 |
2-Bromoquinoxaline, 97% |
| H61959 |
98027-27-1 |
5-Bromothiophene-2-carboxylic acid hydrazide, 98% |
| H61526 |
|
N-tert-Butyl-2,5-difluorobenzamide, 97% |
| H62064 |
145549-76-4 |
tert-Butyl 3-oxocyclobutanecarboxylate, 97% |
| H55521 |
132794-07-1 |
4-Chloro-2,5-difluorobenzoic acid, 98% |
| H61020 |
|
N-(3-Chloro-4-fluorophenyl)-2,5-difluorobenzamide, 97% |
| H61866 |
329794-28-7 |
2-Chloro-3-fluoropyridine-4-carboxaldehyde, 98% |
| H61059 |
|
N-(3-Chloro-2-methylphenyl)-2,5-difluorobenzamide, 97% |
| H61128 |
|
N-(3-Chloro-2-methylphenyl)-3,5-difluorobenzamide, 97% |
| H61099 |
|
N-(2-Chlorophenyl)-2,5-difluorobenzamide, 97% |
| H61006 |
|
N-(3-Chlorophenyl)-2,5-difluorobenzamide, 97% |
| H61036 |
|
N-(4-Chlorophenyl)-2,5-difluorobenzamide, 97% |
| H61474 |
42518-98-9 |
5-Chlorothiophene-2-carbonyl chloride, 98% |
| H61805 |
772-49-6 |
1-Chloro-3-(trifluoromethoxy)benzene, 98% |
| H62292 |
1387445-51-3 |
cis-4-Cyanocyclohexylamine hydrochloride, 97% |
| H62938 |
920966-30-9 |
trans-3-Cyanocyclohexylamine hydrochloride, 97% |
| H62522 |
873537-33-8 |
trans-4-Cyanocyclohexylamine hydrochloride, 97% |
| H61390 |
|
N-Cyclopentyl-3,5-difluorobenzamide, 97% |
| H62441 |
133332-49-7 |
3-Cyclopentyloxy-4-methoxybenzyl alcohol, 97% |
| H61838 |
|
N-(2,4-Dibromophenyl)-2,5-difluorobenzamide, 97% |
| H57211 |
1036448-49-3 |
2,5-Dichloro-N-(3-fluorobenzyl)aniline, 97% |
| H61556 |
131401-55-3 |
N,N-Diethyl-2,5-difluorobenzamide, 97% |
| H61839 |
|
N,N-Diethyl-3,5-difluorobenzamide, 97% |
| H61085 |
|
2,5-Difluoro-N-(2,4-difluorophenyl)benzamide, 97% |
| H61064 |
|
2,5-Difluoro-N-(2,5-difluorophenyl)benzamide, 97% |
| H61068 |
|
2,5-Difluoro-N-(3,4-difluorophenyl)benzamide, 97% |
| H61084 |
|
2,5-Difluoro-N-(3,5-difluorophenyl)benzamide, 97% |
| H61956 |
|
2,5-Difluoro-N,N-dimethylbenzamide, 97% |
| H61051 |
|
2,5-Difluoro-N-(2,4-dimethylphenyl)benzamide, 97% |
| H61055 |
|
2,5-Difluoro-N-(2,5-dimethylphenyl)benzamide, 97% |
| H61003 |
|
2,5-Difluoro-N-(3,4-dimethylphenyl)benzamide, 97% |
| H61042 |
|
2,5-Difluoro-N-(3,5-dimethylphenyl)benzamide, 97% |
| H61249 |
|
2,5-Difluoro-N,N-di-n-propylbenzamide, 97% |
| H61013 |
|
2,5-Difluoro-N-(2-fluorobenzyl)benzamide, 97% |
| H61043 |
|
2,5-Difluoro-N-(3-fluorobenzyl)benzamide, 97% |
| H61069 |
|
2,5-Difluoro-N-(4-fluorobenzyl)benzamide, 97% |
| H61540 |
|
2,5-Difluoro-N-(2-fluoro-3-methylphenyl)benzamide, 97% |
| H61348 |
|
2,5-Difluoro-N-(2-fluoro-4-methylphenyl)benzamide, 97% |
| H61541 |
|
2,5-Difluoro-N-(3-fluoro-4-methylphenyl)benzamide, 97% |
| H61242 |
|
2,5-Difluoro-N-(3-fluoro-5-methylphenyl)benzamide, 97% |
| H61443 |
|
2,5-Difluoro-N-(4-fluoro-2-methylphenyl)benzamide, 97% |
| H61512 |
|
2,5-Difluoro-N-(5-fluoro-2-methylphenyl)benzamide, 97% |
| H61015 |
|
2,5-Difluoro-N-(2-fluorophenyl)benzamide, 97% |
| H61016 |
|
2,5-Difluoro-N-(3-fluorophenyl)benzamide, 97% |
| H61072 |
|
2,5-Difluoro-N-(4-fluorophenyl)benzamide, 97% |
| H61324 |
|
2,5-Difluoro-N-isopropylbenzamide, 97% |
| H61199 |
|
3,5-Difluoro-N-isopropylbenzamide, 97% |
| H61923 |
|
2,5-Difluoro-N-methylbenzamide, 97% |
| H61054 |
|
2,5-Difluoro-N-(3-methylbenzyl)benzamide, 97% |
| H61073 |
|
2,5-Difluoro-N-(4-methylbenzyl)benzamide, 97% |
| H61530 |
1150114-28-5 |
2,6-Difluoro-3-nitrobenzeneboronic acid, 96% |
| H61086 |
|
2,5-Difluoro-N-phenylbenzamide, 97% |
| H61762 |
|
2,5-Difluoro-N-n-propylbenzamide, 97% |
| H61046 |
|
2,5-Difluoro-N-[2-(trifluoromethyl)phenyl]benzamide, 97% |
| H61024 |
|
2,5-Difluoro-N-[3-(trifluoromethyl)phenyl]benzamide, 97% |
| H61009 |
|
2,5-Difluoro-N-[4-(trifluoromethyl)phenyl]benzamide, 97% |
| H61817 |
25252-46-4 |
1,3-Dimethyl-1H-thieno[2,3-c]pyrazole-5-carboxylic acid, 95% |
| H61163 |
|
N-Ethyl-2,5-difluorobenzamide, 97% |
| H61813 |
1999-00-4 |
Ethyl (4-fluorobenzoyl)acetate, 98% |
| H62566 |
1195-81-9 |
Ethyl 1-(hydroxymethyl)cyclobutanecarboxylate, 97% |
| H62519 |
834914-39-5 |
Ethyl 1-(hydroxymethyl)cyclohexanecarboxylate, 97% |
| H62804 |
1075-82-7 |
Ethyl 1-(hydroxymethyl)cyclopentanecarboxylate, 97% |
| H62277 |
3697-68-5 |
Ethyl 1-(hydroxymethyl)cyclopropanecarboxylate, 97% |
| H62920 |
|
Ethyl trans-2-(hydroxymethyl)cyclopropanecarboxylate, 97% |
| H62420 |
87121-89-9 |
Ethyl 3-oxocyclobutanecarboxylate, 97% |
| H36903 |
55341-62-3 |
9-Fluorenone-1-carbonyl chloride, 95% |
| H37935 |
42135-37-5 |
9-Fluorenone-1-carboxamide, 97% |
| H61319 |
328956-08-7 |
6-Fluoro-2-hydroxy-4-(trifluoromethyl)quinoline, 97% |
| H61143 |
1978-33-2 |
2-Fluoro-3-methylaniline, 98% |
| H61410 |
32004-66-3 |
5-Fluoro-2-methyl-1H-indene-3-acetic acid, 97% |
| H62395 |
79990-15-1 |
N-Fmoc-D-alanine, 95% |
| H62680 |
134098-70-7 |
N-Fmoc-D-aspartic acid 1-tert-butyl ester, 95% |
| H62356 |
112883-39-3 |
N-Fmoc-D-aspartic acid 4-tert-butyl ester, 98% |
| H62765 |
118488-18-9 |
N-Fmoc-O-tert-butyl-D-tyrosine, 95% |
| H62936 |
121343-82-6 |
N-Fmoc-L-glutamic acid, 95% |
| H62178 |
112883-40-6 |
N-Fmoc-D-methionine, 98% |
| H62504 |
135610-90-1 |
Nalpha-Fmoc-1-trityl-D-histidine, 98% |
| H61377 |
766-55-2 |
Imidazo[1,2-b]pyridazine, 98% |
| H61788 |
22960-16-3 |
Isoquinoline-4-carboxaldehyde, 97% |
| H62024 |
712313-64-9 |
Methyl trans-3-aminocyclohexanecarboxylate hydrochloride, 97% |
| H62562 |
61367-07-5 |
Methyl trans-4-aminocyclohexanecarboxylate hydrochloride, 97% |
| H61749 |
2475-81-2 |
Methyl 2-amino-4-fluorobenzoate, 98% |
| H62560 |
1035325-22-4 |
Methyl trans-3-(benzyloxycarbonylamino)cyclohexanecarboxylate, 97% |
| H36865 |
206551-41-9 |
Methyl 3-bromo-2-fluorobenzoate, 98% |
| H62110 |
695-95-4 |
Methyl 3-oxocyclobutanecarboxylate, 97% |
| H61613 |
82294-70-0 |
4-Methylthiazole-5-carboxaldehyde, 97% |
| H61924 |
113100-53-1 |
1-Methyl-3-trifluoromethyl-1H-pyrazole-4-carboxylic acid, 97% |
| H61292 |
1986-81-8 |
Nicotinamide N-oxide, 98% |
| H55772 |
13138-53-9 |
4-Nitrophthalamide, 99% |
| H37441 |
|
(R,R)-N-(Pentafluorobenzenesulfonyl)-1,2-diphenylethanediamine, 98% |
| H36200 |
|
(S,S)-N-(Pentafluorobenzenesulfonyl)-1,2-diphenylethanediamine, 98% |
| H61130 |
13249-63-3 |
Phenyl bis(2-chloroethyl)carbamate, 98% |
| H37001 |
|
(S)-PhEt-(S,S)-BoPhoz, 98% |
| H36628 |
|
(S)-PhEt-(S,S)-BoPhozRuCl2ampy, 98% |
| H63246 |
1150655-10-9 |
Potassium 2,4-bis(trifluoromethyl)phenyltrifluoroborate, 95% |
| 12177 |
16871-60-6 |
Potassium hexachloroosmate(IV), Os 38.7% min |
| H63839 |
888711-47-5 |
Potassium (iodomethyl)trifluoroborate, tech. 90% |
| H36527 |
89171-23-3 |
Potassium tetrakis(pentafluorophenyl)borate, 97% |
| 47002 |
12137-27-8 |
Rhodium(IV) oxide, Rh 75.2-77.4% |
| 47004 |
161401-25-8 |
Tetramethylammonium bis(trifluoromethylsulfonyl)imide, 97% |
| H61428 |
41507-35-1 |
Thiophene-3-carbonyl chloride, 97% |
| H61487 |
27757-86-4 |
3-Thiophenemethylamine, 97% |
| H55493 |
3091-32-5 |
Tricyclohexyltin chloride, 97% |
| H61380 |
179756-91-3 |
1-[4-(Trifluoromethyl)-2-pyrimidinyl]piperazine, 97% |
| H37887 |
|
(R,R)-N-(2,4,6-Trimethylbenzenesulfonyl)-1,2-diphenylethanediamine, 98% |
| H36824 |
|
(S,S)-N-(2,4,6-Trimethylbenzenesulfonyl)-1,2-diphenylethanediamine, 98% |
| H62194 |
23234-43-7 |
D-Tyrosine ethyl ester hydrochloride, 98% |
| H36621 |
100-43-6 |
4-Vinylpyridine, 96%, low polymer, stab. with 100ppm hydroquinone |
| H36691 |
7440-44-0 |
Carbon powder, activated, Norit® D10 |
| 96155 |
|
Spectroflux 161A, Lithium tetraborate, Lithium metaborate, & Lithium nitrate, 45:45:10 w/w% |
| J66524 |
|
2F5 epitope |
| J66492 |
|
N-Acetyl-Adhesin (1025-1044) amide |
| J66257 |
|
N-Acetyl-Adrenocorticotropic Hormone (1-17), human |
| J66221 |
|
N-Acetyl-Asp-Glu-Val-Asp-chlormethyl ketone |
| J66171 |
168135-79-3 |
N-Acetyl-Asp-Tyr(2-malonyl)-Val-Pro-Met-Leu-NH2 |
| J66744 |
|
N-Acetyl-Asp-Tyr(PO3H2)-Val-Pro-Met-Leu-NH2 |
| J66680 |
123714-50-1 |
N-Acetyl-Calpastatin (184-210), human |
| J66056 |
|
N-Acetyl Cholecystokinin, CCK (26-30), sulfated |
| J66976 |
|
N-Acetyl Cholecystokinin, CCK (26-31), non-sulfated |
| J66989 |
|
N-Acetyl Cholecystokinin, CCK (26-31), sulfated |
| J66214 |
143037-33-6 |
N-Acetyl-[D-Trp16] Endothelin-1 (16-21), human |
| J66512 |
|
N-Acetyl-Endothelin-1 (16-21), human |
| J66897 |
|
N-Acetyl-Glu-Glu-Val-Val-Pro-Cys-p-nitroanilide |
| J66294 |
|
N-Acetyl-Ile-Glu-Pro-Asp-al |
| J66985 |
191338-86-0 |
N-Acetyl-Ile-Glu-Thr-Asp-al |
| J66787 |
|
N-Acetyl-Leu-Glu-His-Asp-al |
| J66335 |
292633-16-0 |
N-Acetyl-Leu-Glu-His-Asp-7-amino-4-methylcoumarin |
| J66917 |
28575-34-0 |
N-Acetyl-Pepstatin |
| J66430 |
127103-11-1 |
N-Acetyl-Ser-Asp-Lys-Pro |
| J66829 |
127103-11-1 |
N-Acetyl-Ser-Asp-Lys-Pro |
| J66080 |
121822-32-0 |
N-Acetyl-Ser-Gln-Asn-Tyr-Pro-Val-Val-NH2 |
| J66475 |
189275-74-9 |
N-Acetyl-Trp-Glu-His-Asp-7-amino-4-methylcoumarin |
| J66566 |
|
N-Acetyl-Tyr-Glu-Val-Asp-p-nitroanilide |
| J66571 |
290814-90-3 |
N-Acetyl-Tyr-(N-Methyl)-Val-Ala-(N-Methyl)-Asp-al |
| J66329 |
219137-85-6 |
N-Acetyl-Tyr-Val-Ala-Asp-7-amino-4-trifluoromethylcomarin |
| J66655 |
|
N-Acetyl-Tyr-Val-Ala-Asp-fluoroacyloxymethyl ketone |
| J66636 |
|
N-Acetyl-Tyr-Val-Lys-Asp-al |
| J66089 |
|
N-Acetyl-Val-Asp-Val-Ala-Asp-7-amino-4-methylcoumarin |
| J66696 |
147837-52-3 |
N-Acetyl-Val-Ala-Asp-al |
| J66501 |
9012-36-6 |
Agarose, Electrophoresis Grade |
| J66208 |
9012-36-6 |
Agarose, Genetic Technology Grade |
| J66704 |
9012-36-6 |
Agarose, high gelling temperature, Molecular Biology Grade |
| J66369 |
9012-36-6 |
Agarose, low EEO |
| J66319 |
9012-36-6 |
Agarose, low gelling temperature, Molecular Biology Grade |
| J66149 |
90105-47-8 |
Ala-Ala-Pro-Val-choloromethyl ketone |
| J66964 |
64263-99-6 |
Ala-Gly-Asp-Val |
| J66857 |
84676-48-2 |
Ala-Leu-Ala-Leu |
| J66283 |
100307-95-7 |
2-Aminobenzoyl-Ala-Gly-Leu-Ala-p-nitrobenzylamide |
| J66907 |
|
[Asn1,Val5] Angiotensin II |
| J66177 |
|
[Ile7] Angiotensin III |
| J66071 |
66641-26-7 |
Acetyl Angiotensinogen (1-14), porcine |
| J66284 |
104180-27-0 |
N-Acetyl Angiotensinogen (1-14), human |
| J67000 |
|
L-Asp-Asp-rhodamine trifluoroacetate salt |
| J66558 |
|
[Met(O)12] Atrial Natriuretic Pepetide (1-28), human |
| J66452 |
|
[Tyr8] Atrial Natriuretic Peptide (5-27), rat |
| J66911 |
|
gamma-Bag Cell Peptide |
| J66075 |
|
Benzoyl-Phe-Ala-Arg |
| J66203 |
|
Biotinyl-[Glu1]-Gastrin I, human |
| J66905 |
|
Biotinyl-[Glu1]-Gastrin I, human, (phosphorylated) |
| J66629 |
|
Biotin-Neuropeptide Y, human, rat |
| J66346 |
|
Biotinyl-PTH-Related Protein (1-34), human, rat |
| J66175 |
118850-78-5 |
N-Boc-Ala-Gly-Pro-Arg-7-amino-4-methylcoumarin |
| J66336 |
136132-77-9 |
N-Boc-Arg-Val-Arg-Arg-7-amino-4-methylcoumarin |
| J66738 |
103545-18-2 |
[Lys0-Ala3] Bradykinin |
| J66552 |
32222-00-7 |
[Tyr8] Bradykinin |
| J66295 |
33289-76-8 |
[Tyr0] Bradykinin |
| J66404 |
130942-96-0 |
[D-Arg0, Hyp3, Thi558, D-Phe7]-Adamantaneacetyl Bradykinin |
| J66709 |
|
[D-Arg0, Hyp3, Thi558, D-Phe7]-Admantanecarbonyl Bradykinin |
| J66795 |
|
cAMP Dependent PK Inhibitor, PKI (14-24), amide |
| J66438 |
99534-03-9 |
cAMP Dependent Protein Kinase Inhibitor (PKI 5-24) |
| J66289 |
|
[D-Ala2, Met5] beta-Casomorphin (1-5), bovine |
| J66534 |
|
[D-Ala2] beta-Casomorphin (1-4) amide, bovine |
| J66522 |
|
[D-Ala2] beta-Casomorphin (1-5) amide, bovine |
| J66851 |
|
[D-Ala2] beta-Casomorphin (1-5), bovine |
| J66941 |
|
[D-Ala2] beta-Casomorphin (1-6), bovine |
| J66979 |
74135-04-9 |
beta-Casomorphin (1-4), amide, bovine |
| J66394 |
74171-19-0 |
beta-Casomorphin (1-4), bovine |
| J66178 |
83936-21-4 |
beta-Casomorphin (1-5), amide, bovine |
| J66912 |
72122-63-5 |
beta-Casomorphin (1-5), bovine |
| J66405 |
77434-43-6 |
beta-Casomorphin (1-6), bovine |
| J66290 |
102029-98-1 |
[D-Ala2, Hyp4, Tyr5] beta-Casomorphin (1-5) amide |
| J66782 |
72122-59-9 |
beta-Casomorphin (1-3) |
| J66008 |
|
beta-Casomorphin (1-3), amide |
| J66300 |
|
Caspase-3 Inhibitor I, cell permeable |
| J66974 |
|
Caspase 2 Substrate, chromogenic |
| J66881 |
189696-20-6 |
Caspase-3 Substrate III, fluorogenic |
| J66767 |
|
Caspase-3 Substrate V, fluorogenic |
| J66513 |
|
Caspase-7 Substrate I, fluorogenic |
| J66050 |
|
Caspase-8 Inhibitor I, cell permeable |
| J66253 |
77568-41-3 |
[Thr28, Nle31] Cholecystokinin (25-33), sulfated |
| J66668 |
|
[Cys21] Corticotropin Releasing Factor, human, rat |
| J66247 |
|
[D-Phe12, Nle21238, Glu30, Lys33] Corticotropin Releasing Factor (12-41), human |
| J66399 |
113527-49-4 |
Dansyl-Tyr-Val-Gly |
| J66293 |
88373-73-3 |
DPDPE |
| J66866 |
|
[D-Ala2, D-Arg6] Dynorphin A, (1-13), porcine |
| J66919 |
125357-12-2 |
[D-Arg8] Dynorphin A (1-13), porcine |
| J66231 |
88373-72-2 |
[D-Pen2, D-Pen5] Enkephalin |
| J66865 |
100929-50-8 |
[D-Ala2, D-Met5] Enkephalin |
| J66580 |
61370-87-4 |
[D-Ala2] Met-Enkephalin |
| J66077 |
|
[Ala2] Met-Enkephalin, amide |
| J66689 |
100929-50-8 |
[D-Ala2] Met-Enkephalin amide |
| J66105 |
|
[Arg0] Met-Enkephalin |
| J66236 |
89991-90-2 |
[Cys(Acm)20031] Epidermal Growth Factor (20-31) |
| J66132 |
103226-11-5 |
[Tyr0] Fibrinopeptide A, human |
| J66258 |
125455-56-3 |
[Tyr15] Fibrinopeptide B, human |
| J66850 |
729589-58-6 |
2-Furoyl-Leu-Ile-Gly-Arg-Leu-Orn-NH2 |
| J66456 |
|
[Des-His1, Glu9] Glucagon |
| J66053 |
|
Biotinyl-Glucagon (1-29), human, bovine, porcine |
| J66732 |
|
Biotin-Glucagon Like Peptide 1 (7-36) amide, human |
| J66445 |
188818-21-5 |
Glu-Glu-Lys-Leu-Ile-Val-Val-Ala-Phe |
| J66969 |
150525-67-0 |
Glu-Ile-Leu-Asp-Val |
| J66722 |
|
Glu-Ile-Leu-Glu-Val-Pro-Ser-Thr |
| J66139 |
91037-75-1 |
Gly-Arg-Gly-Asp-Ser-Pro |
| J66048 |
126646-79-5 |
Gly-Arg-Gly-Asp-Ser-Pro-Cys |
| J66611 |
|
Gly-D-Arg-Gly-Asp-Ser-Pro |
| J66799 |
|
Gly-D-Arg-Gly-Asp-Ser-Pro-Ala-Ser-Ser-Lys |
| J66560 |
111844-17-8 |
Gly-Pen-Gly-Arg-Gly-Asp-Ser-Pro-Cys-Ala (Disulfide bridge: Pen2-Cys9) |
| J66436 |
|
Gly-Phe-Arg |
| J66518 |
91826-20-9 |
Growth Hormone Releasing Factor (1-29) amide, rat |
| J66962 |
116283-54-6 |
[Leu13] Motilin, human, porcine |
| J66270 |
50881-15-7 |
[Nle13, Glu14] Motilin, human, porcine |
| J66044 |
|
[Nle13]-Motillin |
| J66603 |
|
Acetyl-Myelin Basic Protein (1-11), human, rat |
| J66946 |
|
Acetyl-Myelin Basic Protein (4-14) Peptide |
| J66176 |
98474-59-0 |
Des-[Gly77, His78] Myelin Basic Protein (68-84), bovine |
| J66467 |
136132-68-8 |
[Glp4] Myelin Basic Protein (4-14) |
| J66216 |
114882-65-4 |
gamma-Neuropeptide, rabbit |
| J66162 |
128768-54-7 |
[Pro34] Neuropeptide Y, porcine |
| J66309 |
|
[Thr30] Neuropeptide Y, human |
| J66699 |
125580-28-1 |
[Leu31, Pro34] Neuropeptide Y (1-36), porcine |
| J66967 |
74853-69-3 |
Acetyl-Neurotensin (8-13) |
| J66489 |
139026-64-5 |
[Lys889] Neurotensin (8-13) |
| J66150 |
|
[Tyr0, Nle8] Pancreastatin, porcine |
| J66424 |
106362-34-9 |
[D-Ala1] Peptide T, amide |
| J66148 |
179986-95-9 |
[Leu31, Pro34] Peptide YY, human |
| J66670 |
115388-96-0 |
D-Phe-Pro-Lys-p-nitroanilide |
| J66073 |
|
Protein Kinase C-delta Peptide Substrate |
| J66938 |
|
Protein Kinase C-epsilon Peptide Substrate |
| J66521 |
|
Protein Kinase C-epsilon Translocation Inhibitor Peptide, Negative Control |
| J66327 |
114991-28-5 |
R15K, HIV-1 Inhibitory Peptide |
| J66067 |
|
[Cys8] Renin Substrate Tetradecapeptide, rat |
| J66131 |
|
[Leu8] Renin Substrate Tetradecapeptide, rat |
| J66550 |
|
[Val8] Renin Substrate Tetradecapeptide, rat |
| J66746 |
116495-45-5 |
[Lys4] Sarafotoxin S6c |
| J66706 |
|
[Arg3] Substance P |
| J66549 |
|
[Cys336, Tyr8, Pro10] Substance P |
| J66988 |
96736-12-8 |
[D-Arg1, D-Phe5, D-Trp779, Leu11] Substance P |
| J66402 |
91224-37-2 |
[D-Arg1, D-Trp779, Leu11] Substance P |
| J66810 |
77275-70-8 |
[D-Pro2, D-Phe7, D-Trp9] Substance P |
| J66971 |
57462-42-7 |
[Nle11] Substance P |
| J66198 |
104486-69-3 |
[Pro9] Substance P |
| J66222 |
77128-75-7 |
[Sar9] Substance P |
| J66679 |
|
[Tyr8, Nle11] Substance P |
| J66577 |
55614-10-3 |
[Tyr8] Substance P |
| J66739 |
145194-26-9 |
[Tyr6, D-Phe7, D-His9] Substance P (6-11) |
| J66653 |
87468-58-4 |
Biotin-Substance P |
| J66654 |
86030-52-6 |
D-Tyr-Val-Gly |
| J66439 |
162303-66-4 |
D-Val-Leu-Arg-p-nitroanilide |
| J66541 |
|
[Arg8] Deamino Vasopressin Desglycinamide |
| J66840 |
37552-33-3 |
[Arg8] Vasopressin Desglycinamide |
| J66929 |
62357-86-2 |
[Deamino-Cys1, Arg8] Vasopressin |
| J66649 |
136105-89-0 |
[Deamino-Cys1, D-3-(Pyridyl)Ala2, Arg8] Vasopressin |
| J66816 |
64158-84-5 |
[Deamino-Pen1, Val4, D-Arg8] Vasopressin |
| J66728 |
50-57-7 |
[Lys8] Vasopressin |
| J66210 |
43157-23-9 |
[Mpr1, Val4, D-Arg8] Vasopressin |
| J66334 |
73168-24-8 |
[Pmp1, Tyr(OMe)2, Arg8] Vasopressin |
| J66551 |
74927-14-3 |
[Arg8] Vasotocin |
| |
| |
| 03 2013 |
| |
| Product No. |
CAS |
Description |
| H61927 |
77326-62-6 |
2-Amino-6-bromobenzonitrile, 95% |
| H61247 |
53312-82-6 |
4-Amino-2-bromobenzonitrile, 95% |
| H55270 |
20358-03-6 |
2-Amino-5-bromobenzothiazole, 97% |
| H61429 |
205672-25-9 |
4-Amino-5-bromo-2-chloropyrimidine, 95% |
| H61264 |
709652-82-4 |
2-Amino-5-bromo-3-cyanopyridine, 97% |
| H61882 |
1479-58-9 |
2-Amino-5-bromo-2'-fluorobenzophenone, 95% |
| H61722 |
39903-01-0 |
2-Amino-5-bromo-3-hydroxypyridine, 95% |
| H61479 |
98786-86-8 |
3-Amino-5-bromo-2-hydroxypyridine, 95% |
| H61952 |
2240-25-7 |
4-Amino-5-bromo-2-hydroxypyrimidine, 98% |
| H61772 |
247582-62-3 |
2-Amino-3-bromopyridine-5-sulfonic acid, 95% |
| H61465 |
164666-68-6 |
3-Amino-6-chloro-2-methylpyridine, 95% |
| H61115 |
66909-38-4 |
5-Amino-2-chloro-4-methylpyridine, 98% |
| H61934 |
33332-28-4 |
2-Amino-6-chloropyrazine, 95% |
| H61344 |
698-29-3 |
4-Amino-5-cyano-2-methylpyrimidine, 95% |
| H61970 |
3512-80-9 |
4-Amino-2,6-dimethylpyridine, 98% |
| H61233 |
2365-85-7 |
3-Amino-4-fluorobenzoic acid, 97% |
| H61617 |
954236-33-0 |
5-Amino-2-fluoro-4-methylpyridine, 95% |
| H61293 |
212268-12-7 |
2-Amino-5-fluoro-3-nitropyridine, 98% |
| H61829 |
62257-16-3 |
3-Amino-4-fluorophenol, 98% |
| H61310 |
186413-79-6 |
3-Amino-2-methoxy-6-methylpyridine, 97% |
| H61990 |
6905-47-1 |
2-Amino-6-methoxypyrazine, 95% |
| H61729 |
21901-29-1 |
2-Amino-6-methyl-3-nitropyridine, 98% |
| H61218 |
22280-62-2 |
6-Amino-2-methyl-3-nitropyridine, 95% |
| H61255 |
19838-08-5 |
2-Amino-3-methylpyrazine, 95% |
| H61286 |
5521-58-4 |
2-Amino-5-methylpyrazine, 98% |
| H61328 |
1744-22-5 |
2-Amino-6-(trifluoromethoxy)benzothiazole, 98% |
| H55702 |
56227-55-5 |
1-Benzoylpiperazine hydrochloride, 97% |
| H61630 |
|
N-Benzyl-3,5-difluorobenzamide, 97% |
| H55708 |
1484-26-0 |
3-Benzyloxyaniline, 98% |
| H61303 |
70097-65-3 |
4-Benzyloxybenzotrifluoride, 95% |
| H55936 |
2051-97-0 |
1-Benzylpyrrole, 97% |
| H60842 |
851870-89-8 |
Bis(2-[(11bR)-3H-binaphtho[2,1-c:1',2'-e]phosphepin-4(5H)-yl]ethyl)amine, 97+% |
| H61964 |
811862-77-8 |
Bis(3,5,3',5'-dimethoxydibenzylideneacetone)palladium(0), Pd 13% |
| H61320 |
187344-92-9 |
Bis(3,5-dimethylphenyl)phosphine oxide, 98% |
| H61504 |
2409-61-2 |
Bis(p-tolyl)phosphine oxide, 98% |
| H61103 |
35480-52-5 |
2,5-Bis(2,2,2-trifluoroethoxy)benzoic acid, 96% |
| H61550 |
116405-43-7 |
Bis(triphenylphosphine)iminium trifluoroacetate, 98% |
| H61853 |
14588-08-0 |
Bis(triphenylphosphine)palladium(II) acetate, Pd 14.2% |
| H37989 |
479719-88-5 |
2,2'-Bithiophene-5-boronic acid pinacol ester, 98% |
| H61828 |
405939-39-1 |
2-(Boc-amino)-5-bromothiazole, 97% |
| H61910 |
369638-68-6 |
2-(Boc-amino)-5-methylpyrazine, 97% |
| H61789 |
57292-45-2 |
N-Boc-4-fluoro-D-phenylalanine, 95% |
| H61370 |
41153-30-4 |
N-Boc-4-fluoro-L-phenylalanine, 95% |
| H37175 |
41593-58-2 |
Borane-diphenylphosphine complex, 98% |
| H55283 |
24856-58-4 |
4-Bromobenzaldehyde dimethyl acetal, 98% |
| H61906 |
928783-85-1 |
3-Bromo-5-chlorobenzotrifluoride, 98% |
| H61978 |
402-04-0 |
4-Bromo-3-chlorobenzotrifluoride, 98% |
| H61664 |
405224-23-9 |
5-Bromo-2-chloro-3-cyanopyridine, 98% |
| H61852 |
63529-30-6 |
2-Bromo-3'-chloro-4'-fluoroacetophenone, 96% |
| H61298 |
195191-47-0 |
2-Bromo-4-chloro-6-fluoroaniline, 98% |
| H61622 |
144584-65-6 |
1-Bromo-3-chloro-2-fluorobenzene, 95% |
| H61116 |
831203-13-5 |
5-Bromo-2-chloro-3-fluoropyridine, 98% |
| H61157 |
884495-15-2 |
5-Bromo-2-chloro-4-methyl-3-nitropyridine, 98% |
| H61873 |
63810-78-6 |
5-Bromo-4-chloro-2-(methylthio)pyrimidine, 95% |
| H61363 |
38275-57-9 |
5-Bromo-2-cyanopyrimidine, 95% |
| H61138 |
14482-51-0 |
2-Bromo-3,5-dichloropyridine, 98% |
| H61876 |
1092349-87-5 |
2-Bromo-3,4-difluoroaniline, 97% |
| H37968 |
3279-90-1 |
6-Bromo-3,4-dihydro-2(1H)-quinolinone, 98% |
| H61282 |
198477-89-3 |
5'-Bromo-2'-fluoroacetophenone, 98% |
| H61687 |
111721-75-6 |
2-Bromo-3-fluoroaniline, 97% |
| H61238 |
134168-97-1 |
3-Bromo-5-fluoroaniline, 95% |
| H61678 |
2924-09-6 |
5-Bromo-2-fluoroaniline, 98% |
| H61251 |
2252-37-1 |
2-Bromo-6-fluorobenzoic acid, 97% |
| H61498 |
79544-27-7 |
2-Bromo-6-fluorobenzonitrile, 97% |
| H61939 |
133059-44-6 |
4-Bromo-3-fluorobenzonitrile, 98% |
| H61850 |
229027-89-8 |
2-Bromo-4-fluorobenzyl alcohol, 98% |
| H61596 |
202865-66-5 |
2-Bromo-5-fluorobenzyl alcohol, 97% |
| H61415 |
216755-56-5 |
3-Bromo-5-fluorobenzyl alcohol, 98% |
| H61399 |
78239-71-1 |
3-Bromo-4-fluorobenzyl bromide, 97% |
| H61954 |
34552-16-4 |
2-Bromo-3-fluoro-5-methylpyridine, 98% |
| H61104 |
17282-01-8 |
3-Bromo-2-fluoro-5-methylpyridine, 98% |
| H61431 |
864830-16-0 |
5-Bromo-2-fluoro-4-methylpyridine, 96% |
| H61840 |
10472-88-5 |
2-Bromo-4-fluoro-6-nitroaniline, 90% |
| H61494 |
185331-69-5 |
1-Bromo-2-fluoro-4-nitrobenzene, 98% |
| H61192 |
7087-65-2 |
1-Bromo-3-fluoro-5-nitrobenzene, 98% |
| H61466 |
700-36-7 |
2-Bromo-4-fluoro-1-nitrobenzene, 98% |
| H61807 |
321-23-3 |
4-Bromo-2-fluoro-1-nitrobenzene, 98% |
| H61500 |
1868-58-2 |
3-Bromo-2-fluoro-5-nitropyridine, 97% |
| H61702 |
27407-11-0 |
3-Bromo-4-fluorophenol, 98% |
| H61518 |
112204-58-7 |
5-Bromo-2-fluorophenol, 98% |
| H61176 |
114897-92-6 |
4-Bromo-2-fluorophenylacetic acid, 98% |
| H61205 |
499983-13-0 |
4-Bromo-3-fluorophenylacetonitrile, 95% |
| H61885 |
|
N-(2-Bromo-4-fluorophenyl)-3,5-difluorobenzamide, 97% |
| H61419 |
|
N-(4-Bromo-3-fluorophenyl)-3,5-difluorobenzamide, 97% |
| H61338 |
345-94-8 |
2-Bromo-1-(4-fluorophenyl)-1-propanone, 98% |
| H61123 |
875781-15-0 |
5-Bromo-2-fluoropyridine-3-carboxaldehyde, 95% |
| H61544 |
202865-83-6 |
3-Bromo-5-fluorotoluene, 98% |
| H61137 |
30186-18-6 |
4'-Bromo-2'-hydroxyacetophenone, 95% |
| H61979 |
1450-75-5 |
5'-Bromo-2'-hydroxyacetophenone, 98% |
| H61361 |
1252046-13-1 |
2-Bromo-5-iodobenzonitrile, 98% |
| H61379 |
43192-31-0 |
2-Bromo-4-methoxybenzaldehyde, 98% |
| H61962 |
126717-59-7 |
3-Bromo-6-methoxy-2-methylpyridine, 98% |
| H61718 |
124432-63-9 |
3-Bromo-2-methoxy-5-(trifluoromethyl)pyridine, 98% |
| H61639 |
53078-85-6 |
2-Bromo-5-methylaniline, 97% |
| H61519 |
74586-53-1 |
3-Bromo-5-methylaniline, 98% |
| H61314 |
24078-12-4 |
4-Bromo-2-methylbenzaldehyde, 95% |
| H61628 |
42872-83-3 |
2-Bromo-5-methylbenzonitrile, 97% |
| H61169 |
7138-15-0 |
3-Bromo-2-nitroaniline, 98% |
| H61975 |
6319-40-0 |
4-Bromo-3-nitrobenzoic acid, 95% |
| H61155 |
65902-59-2 |
2-Bromo-5-nitroimidazole, 98% |
| H61933 |
157026-18-1 |
4-Bromo-2-nitro-6-(trifluoromethyl)aniline, 98% |
| H61393 |
55362-80-6 |
9-Bromo-1-nonanol, 98% |
| H61532 |
|
N-(2-Bromophenyl)-3,5-difluorobenzamide, 97% |
| H61644 |
|
N-(3-Bromophenyl)-3,5-difluorobenzamide, 97% |
| H61600 |
|
N-(4-Bromophenyl)-3,5-difluorobenzamide, 97% |
| H61118 |
25574-11-2 |
3-(4-Bromophenyl)-1-propanol, 98% |
| H61663 |
886762-08-9 |
5-Bromo-2-(trifluoromethoxy)aniline, 98% |
| H61299 |
1214334-83-4 |
2-Bromo-4-(trifluoromethoxy)benzonitrile, 97% |
| H61599 |
402-07-3 |
2-Bromo-5-(trifluoromethyl)anisole, 98% |
| H61947 |
191165-13-6 |
4-Bromo-2-(trifluoromethyl)benzonitrile, 98% |
| H61459 |
1735-53-1 |
4-Bromo-3-(trifluoromethyl)benzonitrile, 98% |
| H61836 |
81107-97-3 |
2-Bromo-4-(trifluoromethyl)phenol, 98% |
| H61913 |
136239-66-2 |
1-n-Butoxy-2,3-difluorobenzene, 95% |
| H61655 |
109010-60-8 |
tert-Butyl (S)-2-(3-amino-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetate, 98% |
| H61945 |
3622-84-2 |
N-n-Butylbenzenesulfonamide, 98% |
| H55320 |
956-61-6 |
1-(4-tert-Butylbenzyl)piperazine, 97% |
| H61703 |
|
N-n-Butyl-3,5-difluorobenzamide, 97% |
| H61228 |
|
N-tert-Butyl-3,5-difluorobenzamide, 97% |
| H55285 |
87184-99-4 |
4-tert-Butyldimethylsiloxy-1-butanol, 97% |
| H61227 |
91424-40-7 |
3-(tert-Butyldimethylsiloxy)glutaric anhydride, 98% |
| H60942 |
81759-25-3 |
1,1'-Carbonyldipyrrolidine, 98% |
| H60106 |
7235-40-7 |
beta-Carotene, 95% |
| H60117 |
11114-20-8 |
kappa-Carrageenan |
| H60869 |
1839-18-5 |
2-Chloroadenine, 97% |
| H61748 |
20532-33-6 |
5-Chlorobenzo[b]thiophene, 97% |
| H55337 |
23145-88-2 |
1-(4-Chlorobenzyl)piperazine, 98% |
| H59154 |
545362-76-3 |
4-Chloro-N-(4-chloro-2-fluorophenyl)benzamide, 97% |
| H61941 |
75833-38-4 |
2-Chloro-4-cyanopyrimidine, 95% |
| H59458 |
881764-20-1 |
2-Chloro-N-(3,5-difluorophenyl)benzamide, 97% |
| H61259 |
81778-09-8 |
2-Chloro-5-fluorobenzyl bromide, 98% |
| H61351 |
122509-72-2 |
6-Chloro-5-fluoroindole, 97% |
| H61972 |
34552-15-3 |
2-Chloro-3-fluoro-5-methylpyridine, 95% |
| H61447 |
38186-84-4 |
2-Chloro-5-fluoro-3-methylpyridine, 95% |
| H61989 |
2106-49-2 |
1-Chloro-2-fluoro-3-nitrobenzene, 97% |
| H61753 |
114776-15-7 |
2-Chloro-4-fluoro-5-nitrobenzoic acid, 97% |
| H61631 |
60186-16-5 |
5-Chloro-2-fluoro-3-nitropyridine, 95% |
| H61841 |
18349-11-6 |
4-Chloro-2-fluoro-5-nitrotoluene, 98% |
| H61416 |
348-62-9 |
4-Chloro-2-fluorophenol, 98% |
| H61909 |
|
N-(3-Chloro-4-fluorophenyl)-3,5-difluorobenzamide, 97% |
| H61932 |
|
N-(4-Chloro-2-fluorophenyl)-3,5-difluorobenzamide, 97% |
| H61911 |
703-82-2 |
6-Chloroindole-3-carboxaldehyde, 98% |
| H55594 |
7477-63-6 |
7-Chloroisatin, 97% |
| H61152 |
52950-19-3 |
(S)-(+)-2-Chloromandelic acid, 95% |
| H55743 |
1006-99-1 |
5-Chloro-2-methylbenzothiazole, 98% |
| H61824 |
4897-25-0 |
5-Chloro-1-methyl-4-nitroimidazole, 95% |
| H61136 |
|
N-(3-Chloro-4-methylphenyl)-3,5-difluorobenzamide, 97% |
| H61929 |
|
N-(4-Chloro-3-methylphenyl)-3,5-difluorobenzamide, 97% |
| H61651 |
95-58-9 |
2-Chloro-3-methylpyrazine, 95% |
| H61792 |
748796-39-6 |
5-Chloromethyl-2-(1H-pyrazol-1-yl)pyridine, 97% |
| H61626 |
72093-04-0 |
3-Chloro-4-methylpyridine, 95% |
| H61643 |
55408-11-2 |
5-Chloromethyl-1H-tetrazole, 95% |
| H61620 |
16097-63-5 |
4-Chloro-2-methylthio-6-(trifluoromethyl)pyrimidine, 97% |
| H61141 |
57531-37-0 |
2-Chloro-5-nitroimidazole, 95% |
| H61365 |
|
N-(2-Chlorophenyl)-3,5-difluorobenzamide, 97% |
| H61999 |
|
N-(3-Chlorophenyl)-3,5-difluorobenzamide, 97% |
| H61870 |
|
N-(4-Chlorophenyl)-3,5-difluorobenzamide, 97% |
| H59896 |
65369-76-8 |
1-(3-Chlorophenyl)piperazine hydrochloride, 97% |
| H61851 |
38944-14-8 |
2-(4-Chlorophenyl)pyrrolidine, 95% |
| H61837 |
19064-67-6 |
6-Chloro-3(2H)-pyridazinone, 98% |
| H61433 |
142569-70-8 |
2-(2-[3-(S)-(3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl)-3-hydroxy-n-propyl]phenyl)-2-propanol, 95% |
| H63779 |
7306-68-5 |
6-Chloro-9-(2-tetrahydropyranyl)purine, 99% |
| H61936 |
141109-19-5 |
2-Chloro-N-[2-(2-thienyl)ethyl]-D-phenylglycine methyl ester hydrochloride, 98% |
| H61768 |
129604-27-9 |
3'-Chloro-4'-(trifluoromethoxy)acetophenone, 98% |
| H61594 |
113770-88-0 |
4-Cyano-3-fluoropyridine, 95% |
| H61201 |
67333-70-4 |
(1S,2S)-(-)-1,2-Diaminocyclohexane D-tartrate, 98% |
| H61181 |
33243-33-3 |
2',4'-Dibromoacetophenone, 98% |
| H61424 |
401-84-3 |
3,5-Dibromobenzotrifluoride, 96% |
| H61506 |
40360-47-2 |
3,5-Dibromo-2-chloropyridine, 98% |
| H61108 |
156772-60-0 |
2,5-Dibromo-3-fluoropyridine, 95% |
| H61738 |
51686-78-3 |
1,3-Dibromo-4-nitrobenzene, 98% |
| H61961 |
15862-37-0 |
2,5-Dibromo-3-nitropyridine, 98% |
| H61468 |
23229-25-6 |
2,6-Dibromopyrazine, 95% |
| H61223 |
17973-86-3 |
3,6-Dibromopyridazine, 95% |
| H60306 |
526-78-3 |
2,3-Dibromosuccinic acid, 98% |
| H61407 |
79623-38-4 |
2,3-Dibromo-5-(trifluoromethyl)pyridine, 95% |
| H55207 |
1020-31-1 |
3,5-Di-tert-butylcatechol, 99% |
| H61405 |
2492-23-1 |
(2,4-Dichlorobenzyl)triphenylphosphonium chloride, 98% |
| H55848 |
15307-93-4 |
2,6-Dichlorodiphenylamine, 98% |
| H61705 |
161612-68-6 |
2,4-Dichloro-3-fluorobenzonitrile, 98% |
| H61321 |
3107-19-5 |
3,5-Dichloro-4-fluoro-1-nitrobenzene, 95% |
| H61770 |
213265-83-9 |
4,6-Dichloro-5-fluoropyrimidine, 98% |
| H61166 |
150728-13-5 |
4,6-Dichloro-5-(2-methoxyphenoxy)-2,2'-bipyrimidine, 95% |
| H61634 |
56961-78-5 |
2,4-Dichloro-5-methylpyridine, 96% |
| H61271 |
58584-94-4 |
2,6-Dichloro-3-methylpyridine, 98% |
| H61767 |
39621-00-6 |
2,6-Dichloro-4-methylpyridine, 95% |
| H61893 |
50594-31-5 |
4,5-Dichloro-2-nitrobenzotrifluoride, 98% |
| H61301 |
|
N-(2,3-Dichlorophenyl)-3,5-difluorobenzamide, 97% |
| H61151 |
|
N-(2,4-Dichlorophenyl)-3,5-difluorobenzamide, 97% |
| H61914 |
303111-96-8 |
Dicyclohexyl(2,4,6-triisopropylphenyl)phosphine, 97% |
| H55053 |
649-15-0 |
N,N-Diethyl-4-methylbenzenesulfonamide, 97% |
| H61525 |
1073372-07-2 |
2,4-Difluorobenzeneboronic acid 1,3-propanediol ester, 98% |
| H61864 |
108966-71-8 |
3,4-Difluorobenzenesulfonamide, 97% |
| H61868 |
147700-58-1 |
trans-3,5-Difluorocinnamic acid, 99% |
| H61127 |
|
3,5-Difluoro-N-(2,4-difluorophenyl)benzamide, 97% |
| H61184 |
|
3,5-Difluoro-N-(2,5-difluorophenyl)benzamide, 97% |
| H61958 |
|
3,5-Difluoro-N-(3,4-difluorophenyl)benzamide, 97% |
| H61289 |
|
3,5-Difluoro-N-(3,5-difluorophenyl)benzamide, 97% |
| H61269 |
|
3,5-Difluoro-N,N-dimethylbenzamide, 97% |
| H61437 |
|
3,5-Difluoro-N-(2,3-dimethylphenyl)benzamide, 97% |
| H61436 |
|
3,5-Difluoro-N-(2,4-dimethylphenyl)benzamide, 97% |
| H61175 |
|
3,5-Difluoro-N-(2,5-dimethylphenyl)benzamide, 97% |
| H61563 |
|
3,5-Difluoro-N-(3,4-dimethylphenyl)benzamide, 97% |
| H61288 |
|
3,5-Difluoro-N-(3,5-dimethylphenyl)benzamide, 97% |
| H61439 |
|
3,5-Difluoro-N-(2-fluorobenzyl)benzamide, 97% |
| H61746 |
|
3,5-Difluoro-N-(3-fluorobenzyl)benzamide, 97% |
| H61167 |
|
3,5-Difluoro-N-(4-fluorobenzyl)benzamide, 97% |
| H61898 |
|
3,5-Difluoro-N-(2-fluoro-3-methylphenyl)benzamide, 97% |
| H61215 |
|
3,5-Difluoro-N-(2-fluoro-4-methylphenyl)benzamide, 97% |
| H61212 |
|
3,5-Difluoro-N-(2-fluoro-5-methylphenyl)benzamide, 97% |
| H61469 |
|
3,5-Difluoro-N-(3-fluoro-2-methylphenyl)benzamide, 97% |
| H61567 |
|
3,5-Difluoro-N-(3-fluoro-4-methylphenyl)benzamide, 97% |
| H61764 |
|
3,5-Difluoro-N-(3-fluoro-5-methylphenyl)benzamide, 97% |
| H61245 |
|
3,5-Difluoro-N-(4-fluoro-2-methylphenyl)benzamide, 97% |
| H61435 |
|
3,5-Difluoro-N-(5-fluoro-2-methylphenyl)benzamide, 97% |
| H61680 |
|
3,5-Difluoro-N-(2-fluorophenyl)benzamide, 97% |
| H61863 |
|
3,5-Difluoro-N-(3-fluorophenyl)benzamide, 97% |
| H61812 |
746612-12-4 |
3,5-Difluoro-N-(4-fluorophenyl)benzamide, 97% |
| H61798 |
130137-05-2 |
4,5-Difluoro-2-iodobenzoic acid, 98% |
| H61174 |
102625-64-9 |
5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl)methyl]thio-1H-benzimidazole, 95% |
| H61378 |
|
3,5-Difluoro-N-methylbenzamide, 97% |
| H61371 |
|
3,5-Difluoro-N-(2-methylbenzyl)benzamide, 97% |
| H61457 |
|
3,5-Difluoro-N-(3-methylbenzyl)benzamide, 97% |
| H61263 |
|
3,5-Difluoro-N-(4-methylbenzyl)benzamide, 97% |
| H59759 |
|
2,6-Difluoro-N-(2-methylphenyl)benzamide, 97% |
| H61552 |
|
3,5-Difluoro-N-(2-methylphenyl)benzamide, 97% |
| H61955 |
|
3,5-Difluoro-N-(3-methylphenyl)benzamide, 97% |
| H61388 |
746609-38-1 |
3,5-Difluoro-N-(4-methylphenyl)benzamide, 97% |
| H61430 |
|
3,5-Difluoro-N-phenylbenzamide, 97% |
| H61207 |
|
3-(2,4-Difluorophenyl)-1-phenylurea, 95% |
| H61222 |
|
3-(2,5-Difluorophenyl)-1-phenylurea, 95% |
| H61781 |
|
3-(3,4-Difluorophenyl)-1-phenylurea, 95% |
| H61985 |
|
3-(3,5-Difluorophenyl)-1-phenylurea, 95% |
| H61197 |
212837-49-5 |
2,3-Difluoro-4-n-propoxybenzeneboronic acid, 97% |
| H61881 |
|
3,5-Difluoro-N-n-propylbenzamide, 97% |
| H61887 |
86404-63-9 |
2',4'-Difluoro-2-(1H-1,2,4-triazol-1-yl)acetophenone, 97% |
| H61650 |
1202679-46-6 |
2',4'-Difluoro-3'-(trifluoromethyl)acetophenone, 97% |
| H61903 |
1189359-39-4 |
3',5'-Difluoro-4'-(trifluoromethyl)acetophenone, 97% |
| H61145 |
261945-09-9 |
3,5-Difluoro-4-(trifluoromethyl)benzoic acid, 98% |
| H61241 |
|
3,5-Difluoro-N-[2-(trifluoromethyl)phenyl]benzamide, 97% |
| H61510 |
|
3,5-Difluoro-N-[3-(trifluoromethyl)phenyl]benzamide, 97% |
| H61231 |
|
3,5-Difluoro-N-[4-(trifluoromethyl)phenyl]benzamide, 97% |
| H61341 |
660-27-5 |
Diisopropylamine dichloroacetate, 95% |
| H55471 |
4107-98-6 |
N,N-Diisopropylaniline, 97% |
| H55723 |
28611-39-4 |
4-(Dimethylamino)benzeneboronic acid, 97% |
| H61912 |
54593-26-9 |
3,5-Dimethylisoxazole-4-carboxaldehyde, 97% |
| H61859 |
5294-61-1 |
N-(2,6-Dimethylphenyl)-1-piperazineacetamide, 95% |
| H61425 |
4629-80-5 |
1,3-Dimethyl-4-piperidone, 95% |
| H37099 |
2820-37-3 |
3,4-Dimethyl-1H-pyrazole, 97% |
| H61306 |
50777-76-9 |
2-(Diphenylphosphino)benzaldehyde, 97% |
| H61640 |
13885-09-1 |
2-(Diphenylphosphino)biphenyl, 98% |
| H61685 |
402822-72-4 |
2-Diphenylphosphino-2'-methylbiphenyl, 98% |
| H61281 |
115-46-8 |
Diphenyl(4-piperidinyl)methanol, 95% |
| H55167 |
1579-40-4 |
Di-p-tolyl ether, 99% |
| H36258 |
199002-02-3 |
N(2)-[1-(R/S)-(Ethoxycarbonyl)-3-oxo-3-phenylpropyl]-N(6)-trifluoroacetyl-L-lysine, mixture of isomers |
| H61766 |
4815-32-1 |
Ethyl 2-amino-5-methylthiophene-3-carboxylate, 95% |
| H61625 |
42783-04-0 |
Ethyl 2-amino-5-nitrothiophene-3-carboxylate, 95% |
| H61280 |
13362-30-6 |
Ethyl 2-aminopyridine-4-carboxylate, 97% |
| H61559 |
31891-06-2 |
Ethyl 2-aminothiophene-3-carboxylate, 98% |
| H61633 |
40640-98-0 |
Ethyl 3-(4-bromophenyl)propionate, 95% |
| H61304 |
1197193-30-8 |
Ethyl 5-bromopyrimidine-2-carboxylate, 95% |
| H61701 |
21190-89-6 |
Ethyl 6-chloropyridine-2-carboxylate, 97% |
| H61646 |
|
N-Ethyl-3,5-difluorobenzamide, 97% |
| H61629 |
5744-40-1 |
Ethyl 1,3-dimethyl-1H-pyrazole-5-carboxylate, 95% |
| H61579 |
5744-51-4 |
Ethyl 1,5-dimethyl-1H-pyrazole-3-carboxylate, 97% |
| H61340 |
459-72-3 |
Ethyl fluoroacetate, 98% |
| H61507 |
90315-82-5 |
Ethyl (R)-2-hydroxy-4-phenylbutyrate, 98% |
| H61185 |
30148-21-1 |
Ethyl 1-methylimidazole-2-carboxylate, 95% |
| H61142 |
20582-55-2 |
Ethyl 4-methylthiazole-5-carboxylate, 95% |
| H61472 |
111493-74-4 |
Ethyl 1-methyl-3-trifluoromethyl-1H-pyrazole-4-carboxylate, 97% |
| H61589 |
20826-94-2 |
Ethyl 2-oxocyclopentylacetate, 95% |
| H61359 |
|
N-(4-Ethylphenyl)-3,5-difluorobenzamide, 97% |
| H61453 |
121195-03-7 |
Ethyl 3-(2-thienyl)-1H-pyrazole-5-carboxylate, 95% |
| H61244 |
3032-92-6 |
4-Ethynylbenzonitrile, 97% |
| H61570 |
456-14-4 |
4-Fluorobenzamidine hydrochloride, 95% |
| H61743 |
30058-40-3 |
2-Fluorobenzenesulfonamide, 97% |
| H55740 |
1524-40-9 |
3-Fluorobenzenesulfonamide, 97% |
| H61988 |
4640-67-9 |
4-Fluorobenzoylacetonitrile, 97% |
| H59713 |
546096-46-2 |
N-(2-Fluoro-4-chlorophenyl)-4-methoxybenzamide, 97% |
| H61502 |
114435-02-8 |
4-Fluoro-1,3-dioxolan-2-one, 98% |
| H61665 |
2795-41-7 |
6-Fluoroindole-3-carboxaldehyde, 98% |
| H61427 |
656-66-6 |
3-Fluoro-4-iodoaniline, 98% |
| H61724 |
825-98-9 |
3-Fluoro-4-iodobenzoic acid, 98% |
| H61973 |
137553-42-5 |
2-Fluoro-4-iodobenzonitrile, 98% |
| H61965 |
450-91-9 |
4-Fluoro-2-methoxyaniline, 95% |
| H61679 |
345-89-1 |
4-Fluoro-4'-methoxybenzophenone, 98% |
| H54439 |
399-30-4 |
2-Fluoro-N-methylbenzylamine, 95% |
| H61877 |
18605-16-8 |
6-Fluoro-2-methyl-3-nitropyridine, 98% |
| H61111 |
|
3-(3-Fluoro-2-methylphenyl)-1-phenylurea, 95% |
| H61598 |
|
3-(4-Fluoro-2-methylphenyl)-1-phenylurea, 95% |
| H61162 |
402-66-4 |
5-Fluoronicotinic acid, 98% |
| H61843 |
567-63-5 |
3-Fluoro-2-nitroaniline, 98% |
| H61806 |
2369-11-1 |
5-Fluoro-2-nitroaniline, 97% |
| H61110 |
445-83-0 |
4-Fluoro-2-nitroanisole, 98% |
| H61554 |
61324-93-4 |
4-Fluoro-3-nitroanisole, 95% |
| H61971 |
2923-96-8 |
4-Fluoro-2-nitrobenzaldehyde, 98% |
| H61670 |
385-01-3 |
3-Fluoro-2-nitrophenol, 97% |
| H61940 |
2689-39-6 |
4-(2-Fluoro-4-nitrophenyl)morpholine, 98% |
| H61260 |
1480-87-1 |
2-Fluoro-3-nitropyridine, 98% |
| H61100 |
499-08-1 |
3-Fluoro-5-nitrotoluene, 98% |
| H61511 |
71294-03-6 |
7-Fluorooxindole, 95% |
| H61202 |
68359-57-9 |
4-Fluoro-3-phenoxybenzaldehyde, 97% |
| H61535 |
2836-82-0 |
2-Fluorophenylacetone, 98% |
| H61928 |
151157-48-1 |
1-(2-Fluorophenyl)cyclobutanecarboxylic acid, 98% |
| H61476 |
6264-67-1 |
4-Fluoro-1,3-phenylenediamine, 95% |
| H61791 |
1583-88-6 |
2-(4-Fluorophenyl)ethylamine, 97% |
| H61129 |
147118-37-4 |
N-[4-(4-fluorophenyl)-5-formyl-6-isopropyl-2-pyrimidinyl]-N-methylmethanesulfonamide, 99% |
| H61495 |
19883-57-9 |
4-Fluoro-L-phenylglycine, 98% |
| H61699 |
72216-04-7 |
2-(2-Fluorophenyl)pyrrolidine, 95% |
| H61656 |
72216-06-9 |
2-(4-Fluorophenyl)pyrrolidine, 95% |
| H61902 |
31224-43-8 |
3-Fluoropyridine-2-carboxaldehyde, 98% |
| H61458 |
152126-31-3 |
3-Fluoropyridine-2-carboxylic acid, 98% |
| H57457 |
101555-63-9 |
N-Fmoc-D-pipecolic acid, 96+% |
| H61777 |
2210-74-4 |
Glycidyl 2-methoxyphenyl ether, 98% |
| H61869 |
324-94-7 |
4-Hydroxy-4'-fluorobiphenyl, 98% |
| H61190 |
4349-07-9 |
4-Hydroxy-5-iodopyrimidine, 95% |
| H61586 |
21901-18-8 |
2-Hydroxy-4-methyl-3-nitropyridine, 98% |
| H61404 |
3524-87-6 |
4-Hydroxy-6-methylpyrimidine, 97% |
| H61917 |
5301-78-0 |
4-Hydroxymethyl-2,6,7-trioxa-1-phosphabicyclo[2.2.2]octane 1-oxide, 98% |
| H55152 |
1196-70-9 |
Indole-6-carboxaldehyde, 97% |
| H61539 |
20924-56-5 |
4-Isochromanone, 95% |
| H61739 |
27655-40-9 |
Isoquinoline-5-sulfonic acid, 95% |
| H61536 |
7423-55-4 |
3-Maleimidopropionic acid, 95% |
| H61723 |
162515-68-6 |
1-(Mercaptomethyl)cyclopropaneacetic acid |
| H55673 |
101-16-6 |
3-Methoxydiphenylamine, 98% |
| H61258 |
6635-90-1 |
2-Methoxy-4-methyl-5-nitropyridine, 95% |
| H61395 |
672-89-9 |
4-Methoxy-6-methyl-2H-pyran-2-one, 97% |
| H61996 |
2174-64-3 |
5-Methoxyresorcinol, 95% |
| H61448 |
22223-49-0 |
Methyl 2-amino-3-methylbenzoate, 98% |
| H55579 |
18583-89-6 |
Methyl 3-amino-2-methylbenzoate, 96% |
| H61117 |
18595-14-7 |
Methyl 4-amino-3-methylbenzoate, 98% |
| H61671 |
18595-12-5 |
Methyl 5-amino-3-methylbenzoate, 98% |
| H61641 |
32981-85-4 |
Methyl (2R,3S)-3-benzamido-2-hydroxy-3-phenylpropionate, 98% |
| H55375 |
5321-48-2 |
1-(3-Methylbenzyl)piperazine, 97% |
| H61831 |
131001-86-0 |
Methyl 2-bromo-3-methylbenzoate, 98% |
| H61861 |
79669-50-4 |
Methyl 5-bromo-2-methylbenzoate, 98% |
| H61342 |
66191-86-4 |
Methyl 3-(2-bromophenyl)propionate, 98% |
| H61546 |
75567-84-9 |
Methyl 3-(4-bromophenyl)propionate, 97% |
| H61339 |
89581-38-4 |
Methyl 5-bromopyrimidine-2-carboxylate, 95% |
| H61327 |
84832-01-9 |
Methyl 2,6-difluoro-3-nitrobenzoate, 98% |
| H61343 |
2343-89-7 |
Methyl 2-fluoroacrylate, 95% |
| H61675 |
197507-22-5 |
Methyl 2-fluoro-4-hydroxybenzoate, 98% |
| H61219 |
403-01-0 |
Methyl 3-fluoro-4-hydroxybenzoate, 98% |
| H61302 |
1427-06-1 |
Methyl 6-fluoronicotinate, 95% |
| H61676 |
2965-22-2 |
Methyl 2-fluoro-5-nitrobenzoate, 98% |
| H61542 |
329-59-9 |
Methyl 4-fluoro-3-nitrobenzoate, 98% |
| H61307 |
393-85-1 |
Methyl 5-fluoro-2-nitrobenzoate, 98% |
| H55441 |
4318-37-0 |
1-Methylhomopiperazine, 97% |
| H61907 |
5471-82-9 |
Methyl 3-methyl-2-nitrobenzoate, 98% |
| H60614 |
88054-22-2 |
2-Methyl-5-nitroimidazole, 99% |
| H61750 |
21203-68-9 |
2-Methyl-5-nitropyridine, 95% |
| H61754 |
2971-79-1 |
Methyl piperidine-4-carboxylate, 98% |
| H61397 |
116834-96-9 |
3-Methyl-1H-pyrazolo[3,4-b]pyridine, 95% |
| H61106 |
20873-58-9 |
5-(Methylthio)thiophene-2-carboxylic acid, 97% |
| H61878 |
103577-40-8 |
2-[3-Methyl-4-(2,2,2-trifluoroethoxy)-2-pyridylmethylthio]-1H-benzimidazole, 98% |
| H61779 |
67169-22-6 |
2-Methyl-4-(trifluoromethyl)aniline, 97% |
| H61516 |
154471-65-5 |
1-Methyl-3-trifluoromethyl-1H-pyrazole, 98% |
| H61188 |
3235-69-6 |
4-Morpholineacetic acid hydrochloride, 95% |
| H61800 |
121193-91-7 |
2-(1-Naphthyl)pyrrolidine, 95% |
| H55831 |
121-52-8 |
3-Nitrobenzenesulfonamide, 99% |
| H55744 |
607-57-8 |
2-Nitrofluorene, 98% |
| H61612 |
30450-62-5 |
7-Nitro-1,2,3,4-tetrahydroquinoline, 95% |
| H61672 |
1644-88-8 |
1-Nitro-2-(trifluoromethoxy)benzene, 97% |
| H61402 |
344-39-8 |
4-Nitro-3-(trifluoromethyl)anisole, 96% |
| H61467 |
784-77-0 |
3-Nitro-4-(trifluoromethoxy)benzoic acid, 98% |
| H61452 |
320-37-6 |
4-Nitro-2-(trifluoromethyl)benzoic acid, 97% |
| H60606 |
|
2-Nitro-N-[4-(trifluoromethyl)phenyl]benzenesulfonamide, 97% |
| H55466 |
65016-62-8 |
3-n-Octylthiophene, 97% |
| H61239 |
80-51-3 |
4,4'-Oxybis(benzenesulfonyl hydrazide), 95% |
| 47019 |
|
Palladium, 5% on activated carbon powder, Type A1090475, standard, reduced, nominally 50% water wet |
| H55175 |
934-87-2 |
S-Phenyl thioacetate, 98% |
| H55224 |
67455-41-8 |
4-(1-Piperazinyl)aniline, 97% |
| H37737 |
|
Platinum(IV) nitrate, solution, Pt 15% w/w (cont. Pt) |
| H55276 |
3244-41-5 |
Potassium tetraphenylborate, 97% |
| H61710 |
271-73-8 |
1H-Pyrazolo[3,4-b]pyridine, 97% |
| H61406 |
4595-61-3 |
Pyrimidine-5-carboxylic acid, 95% |
| H55729 |
117-92-0 |
Quinaldine Red, dye content, 95% |
| H37933 |
14808-60-7 |
Sand, washed |
| H61707 |
104484-71-1 |
Sodium 3-(1-naphthylamino)propanesulfonate, 97% |
| H37760 |
148332-36-9 |
2,2':6',2''-Terpyridine-4'-carboxylic acid, 95% |
| H61417 |
5580-80-3 |
2,3,4,5-Tetrafluoroaniline, 98% |
| H61326 |
1835-49-0 |
Tetrafluoroterephthalonitrile, 98% |
| H55490 |
63590-62-5 |
1-(2-Tetrahydrofuroyl)piperazine hydrobromide, 97% |
| H36869 |
39772-62-8 |
N,N,N',N'-Tetrakis(trimethylsilyl)-1,6-hexanediamine, 97% |
| H61949 |
10396-10-8 |
p-Toluenesulfonyl semicarbazide, 95% |
| H61778 |
52-24-4 |
Tri(1-aziridinyl)phosphine sulfide, 98% |
| H55904 |
54663-78-4 |
2-(Tri-n-butylstannyl)thiophene, 97% |
| H61603 |
6226-25-1 |
2,2,2-Trifluoroethyl trifluoromethanesulfonate, 95% |
| H61475 |
17533-08-3 |
2,4,5-Trifluoro-1-iodobenzene, 95% |
| H61513 |
588702-67-4 |
4-(Trifluoromethyl)quinoline-2-carboxylic acid, 95% |
| H61732 |
25199-84-2 |
4-Trifluoromethyl-2(1H)-quinolinone, 97% |
| H61514 |
148416-38-0 |
2,3,4-Trifluoro-6-nitroaniline, 98% |
| H61421 |
193533-92-5 |
2,3,4-Trifluorotoluene, 98% |
| H55719 |
594-31-0 |
Triphenylantimony(V) dichloride, 99% |
| H55656 |
2085-33-8 |
Tris(8-hydroxyquinolinato)aluminum, 99% |
| H37993 |
174813-82-2 |
[(R,R)-TsDPEN-Ru(mesitylene)Cl] |
| H37991 |
|
[(S,S)-TsDPEN-Ru(mesitylene)Cl] |
| 47073 |
7439-95-4 |
Magnesium rod, 6.35mm (0.25in) dia x 25.4mm (1.0in) length, 99.95% (metals basis) |
| J66224 |
|
Adipokinetic Hormone II, Locusta migratoria |
| J66743 |
|
Adipokinetic Hormone II, Schistocera gregaria |
| J66700 |
|
Adipokinetic Hormone, Heliothis zea |
| J66880 |
|
Adipokinetic Hormone, locust |
| J66957 |
|
Adipokinetic Hormone, Tabanus atratus |
| J66066 |
5576-42-1 |
Adrenocorticotropic Hormone (1-16), human |
| J66931 |
7266-47-9 |
Adrenocorticotropic Hormone (1-17), human |
| J66365 |
16960-16-0 |
Adrenocorticotropic Hormone (1-24), human |
| J66508 |
12279-41-3 |
Adrenocorticotropic Hormone (1-39), human |
| J66519 |
77465-10-2 |
Adrenocorticotropic Hormone (1-39), rat |
| J66908 |
|
Adrenocorticotropic Hormone (4-9) |
| J66719 |
4037-01-8 |
Adrenocorticotropic Hormone (4-10), human |
| J66357 |
67224-41-3 |
Adrenocorticotropic Hormone (4-11), human |
| J66352 |
|
Adrenocorticotropic Hormone (6-24), human |
| J66765 |
68563-24-6 |
Adrenocorticotropic Hormone (7-38), human |
| J66844 |
4237-93-8 |
Adrenocorticotropic Hormone (11-24) |
| J66596 |
53917-42-3 |
Adrenocorticotropic Hormone (18-39), human |
| J66956 |
37548-29-1 |
Adrenocorticotropic Hormone (22-39) |
| J66673 |
|
Biotin-Adrenocorticotropic Hormone (1-39), human |
| J66833 |
|
Adrenomedullin (1-12), human |
| J66393 |
|
Adrenomedullin (11-50), rat |
| J66619 |
154765-05-6 |
Adrenomedullin (13-52), human |
| J66493 |
|
Adrenomedullin (1-50), rat |
| J66379 |
148498-78-6 |
Adrenomedullin (1-52), human |
| J66356 |
|
Adrenomedullin (1-52), porcine |
| J66935 |
|
Adrenomedullin (16-31), human, pig |
| J66878 |
159899-65-7 |
Adrenomedullin (22-52), human |
| J66403 |
88377-68-8 |
Adrenorphin |
| J66389 |
|
Adrenorphin, free acid |
| J66635 |
|
Allatostatin I |
| J66779 |
|
Allatostatin II |
| J66599 |
|
Allatostatin III |
| J66648 |
123338-13-6 |
Allatostatin IV |
| J66879 |
347884-61-1 |
Alloferon 1 |
| J66965 |
347884-62-2 |
Alloferon 2 |
| J66314 |
81187-14-6 |
Arg-Lys-Arg-Ser-Arg-Ala-Glu |
| J66926 |
|
Asp-Asp-Asp-Asp-Asp-Asp |
| J66909 |
98849-88-8 |
Asp-Tyr-Lys-Asp-Asp-Asp-Asp-Lys |
| J66863 |
198328-30-2 |
Amylin (1-13), human |
| J66516 |
135702-23-7 |
Amylin (8-37), human |
| J66544 |
135702-23-7 |
Amylin (8-37), rat |
| J66984 |
122384-88-7 |
Amylin, human |
| J66825 |
|
Amylin, human, amide |
| J66161 |
152286-31-2 |
Amyloid beta (10-20) |
| J66499 |
190436-05-6 |
Amyloid beta (1-11) |
| J66562 |
131580-10-4 |
Amyloid beta (1-16) |
| J66757 |
109770-29-8 |
Amyloid beta (1-28) |
| J66913 |
|
Amyloid beta (1-38) |
| J66277 |
|
Amyloid beta (1-40) |
| J66387 |
107761-42-2 |
Amyloid beta (1-42), human |
| J66591 |
|
Amyloid beta (1-42), hydrochloride |
| J66250 |
|
Amyloid beta (1-42), rat |
| J66715 |
144189-71-9 |
Amyloid beta (22-35) |
| J66808 |
131602-53-4 |
Amyloid beta (25-35) |
| J66533 |
149385-65-9 |
Amyloid beta (31-35) |
| J66918 |
151151-30-3 |
Amyloid beta (32-35) |
| J66826 |
147740-73-6 |
Amyloid beta (35-25) |
| J66204 |
|
Amyloid beta (40-1) |
| J66031 |
|
Amyloid beta (42-1) |
| J66535 |
|
Amyloid beta (6-20) |
| J66187 |
|
Angiogenin (108-122) |
| J66320 |
|
Angiogenin (108-123) |
| J66532 |
|
[Val5] Angiotensin I, bovine |
| J66457 |
23025-68-5 |
Angiotensin II (3-8), human |
| J66076 |
|
Angiotensin II Antipeptide |
| J66275 |
|
[Sar1, Ala8] Angiotensin II |
| J66360 |
|
Angiotensin III Antipeptide |
| J66497 |
|
[Sar1, Ile8] Angiotensin II |
| J66892 |
|
[Sar1,Val5, Ala8] Angiotensin II |
| J66431 |
102029-89-0 |
[Sar1] Angiotensin II |
| J66806 |
5649-07-0 |
[Val5] Angiotensin II, human |
| J66542 |
82048-97-3 |
Angiotensinogen (1-13), human |
| J66239 |
64315-16-8 |
Angiotensinogen (1-14), porcine |
| J66045 |
115150-59-9 |
Antagonist G |
| J66464 |
95237-86-8 |
Anxiety Peptide |
| J66079 |
229961-08-4 |
Apelin-12 |
| J66620 |
|
Apelin-13, human, bovine |
| J66238 |
252642-12-9 |
Apelin-36, human |
| J66462 |
|
Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr(PO3H2)-Ala-Ala-Arg-Gly-NH2 |
| J66945 |
81156-93-6 |
Arg-Arg-Leu-Ile-Glu-Asp-Ala-Glu-Tyr-Ala-Ala-Arg-Gly-NH2 |
| J66889 |
59587-24-5 |
Arg-Gly-Tyr-Ala-Leu-Gly |
| J66441 |
|
Arg-Gly-Tyr-Val-Tyr-Gln-Gly-Leu |
| J66858 |
82801-73-8 |
Arg-Lys-Arg-Ala-Arg-Lys-Glu |
| J66241 |
|
Atrial Natriuretic Peptide (1-29), chicken |
| J66958 |
|
Atrial Natriuretic Peptide (1-11), rat |
| J66748 |
|
Atrial Natriuretic Peptide (11-30), frog |
| J66398 |
|
Atrial Natriuretic Peptide (1-28), biotin labeled, human, porcine |
| J66375 |
91917-63-4 |
Atrial Natriuretic Peptide (1-28), human |
| J66658 |
167114-91-2 |
[Ala9] Autocamtide 2 |
| J66170 |
|
Axltide |
| J66855 |
|
Bactenecin, bovine |
| J66153 |
|
beta-Bag Cell Peptide |
| J66473 |
87549-54-0 |
alpha-Bag Cell Peptide (1-7) |
| J66412 |
87549-53-9 |
alpha-Bag Cell Peptide (1-8) |
| J66242 |
|
alpha-Bag Cell Peptide (1-9) |
| J66932 |
75513-71-2 |
BAM-12P |
| J66007 |
321940-50-5 |
BAM-12P (7-12) |
| J66217 |
76622-26-9 |
BAM-22P |
| J66115 |
120796-97-6 |
Big Endothelin-1 (1-38), human |
| J66248 |
124834-83-9 |
Big Endothelin-1 (1-39), bovine |
| J66042 |
120796-99-8 |
Big Endothelin-1 (1-39), porcine |
| J66662 |
135842-15-8 |
Big Endothelin-1 (1-39), rat |
| J66781 |
124932-61-2 |
Big Endothelin-1 (22-38), human |
| J66002 |
|
Big Endothelin-2 (22-37), human |
| J66163 |
|
Big Endothelin-2 (22-38), human |
| J66982 |
60675-77-6 |
Big Gastrin 1, human |
| J66249 |
85679-70-5 |
Bone Gla Protein (45-49) |
| J66567 |
30505-63-6 |
BPP 5a |
| J66169 |
|
BQ-123 |
| J66660 |
143113-45-5 |
BQ-3020 |
| J66937 |
23815-88-5 |
Bradykinin (1-6) |
| J66481 |
23815-87-4 |
Bradykinin (1-7) |
| J66151 |
23828-06-0 |
Bradykinin (2-7) |
| J66218 |
16875-11-9 |
Bradykinin (2-9) |
| J66766 |
86030-63-9 |
[Ile-Ser] Bradykinin |
| J66538 |
71800-37-8 |
Lys-[Des-Arg9, Leu8]-Bradykinin |
| J66701 |
71800-36-7 |
Lys-[Des-Arg9]-Bradykinin |
| J66167 |
124584-08-3 |
Brain Natriuretic Peptide (1-32), human |
| J66536 |
117345-87-6 |
Brain Natriuretic Peptide (1-32), porcine |
| J66043 |
133448-20-1 |
Brain Natriuretic Peptide (1-32), rat |
| J66078 |
123337-89-3 |
Brain Natriuretic Peptide (1-45), rat |
| J66276 |
114547-28-3 |
Brain Natriuretic Peptide (7-32), porcine |
| J66113 |
60267-34-7 |
Bursin |
| J66827 |
96827-03-1 |
Calcitonin Gene Related Peptide, rat |
| J66470 |
129121-73-9 |
Calcitonin Gene Related Peptide (8-37), rat |
| J66762 |
|
Calcitonin Gene Related Peptide II, rat |
| J66428 |
|
Caloxin 2A1 |
| J66597 |
|
CART (1-39), human, rat |
| J66205 |
214050-22-3 |
CART (55-102), human |
| J66118 |
209615-79-2 |
CART (55-102), rat |
| J66304 |
|
CART (55-76), rat |
| J66146 |
|
CART (62-102), human, rat |
| J66530 |
|
CART (62-76), human, rat |
| J66383 |
|
Casein Kinase II Substrate |
| J66861 |
9025-26-7 |
Cathepsin D, bovine spleen |
| J66506 |
9025-26-7 |
Cathepsin D, human liver |
| J66485 |
|
CEF10 |
| J66386 |
|
CEF3 |
| J66896 |
|
CEF4 |
| J66340 |
|
CEF6 |
| J66631 |
94071-26-8 |
Cerebellin |
| J66877 |
95751-30-7 |
Charybdotoxin |
| J66021 |
|
Cholecystokinin (26-33), free acid |
| J66378 |
25679-24-7 |
Cholecystokinin (26-33), non-sulfated |
| J66259 |
198483-37-3 |
Cholecystokinin Flanking Peptide, non-sulfated |
| J66940 |
47910-79-2 |
Cholecystokinin, CCK (27-33) |
| J66669 |
25126-32-3 |
Cholecystokinin, CCK Octapeptide (26-33) |
| J66589 |
5609-49-4 |
Cholecystokinin, CCK Tetrapeptide (30-33) |
| J66711 |
115136-18-0 |
Chromogranin A (324-337), human |
| J66182 |
133633-11-1 |
Chromostatin, bovine |
| J66784 |
94367-21-2 |
Chymotrypsin Substrate III, fluorogenic |
| J66440 |
99273-04-8 |
CKS-17 |
| J66846 |
|
C-Myc Peptide |
| J66466 |
94040-53-6 |
Collagen Binding Fragment |
| J66100 |
93438-65-4 |
Conantokin G |
| J66166 |
|
alpha-Conotoxin EI, Conus ermineus |
| J66628 |
76862-65-2 |
alpha-Conotoxin GI |
| J66642 |
156467-85-5 |
alpha-Conotoxin IMI |
| J66753 |
|
alpha-Conotoxin MI |
| J66745 |
|
alpha-Conotoxin SIA |
| J66997 |
122929-08-2 |
Corazonin |
| J66085 |
|
Corticostatin, human |
| J66487 |
88402-03-3 |
Corticostatin, rabbit |
| J66353 |
92307-52-3 |
Corticotropin Releasing Factor, bovine |
| J66708 |
9015-71-8 |
Corticotropin Releasing Factor, ovine |
| J66413 |
|
Corticotropin Releasing Factor, porcine |
| J66835 |
86784-80-7 |
Corticotropin-Releasing Factor, human, rat |
| J66255 |
186901-48-4 |
Cortistatin 14 |
| J66998 |
|
Cortistatin 29 |
| J66418 |
189450-19-9 |
Cortistatin-17, human |
| J66573 |
|
C-Peptide, dog |
| J66298 |
33017-11-7 |
C-Peptide, human |
| J66434 |
149155-45-3 |
CREBtide |
| J66453 |
|
Crustacean Cardioactive Peptide |
| J66084 |
85916-47-8 |
Crustacean Cardioactive Peptide amide |
| J66367 |
37933-92-9 |
Crustacean Erythrophore Concentrating Hormone |
| J66134 |
7360-09-0 |
Crystalline Peptide |
| J66219 |
103429-32-9 |
CTAP |
| J66595 |
|
C-telopeptide |
| J66263 |
103429-31-8 |
CTOP |
| J66101 |
115722-23-1 |
CTX IV (6-12) |
| J66136 |
|
C-Type Natriuretic Peptide (1-53), human |
| J66540 |
|
C-Type Natriuretic Peptide (32-53), human |
| J66410 |
|
C-Type Natriuretic Peptide, chicken |
| J66125 |
99287-07-7 |
Defensin, human |
| J66391 |
99287-08-8 |
Defensin-1, human |
| J66986 |
136212-91-4 |
Dermaseptin |
| J66523 |
119975-64-3 |
Dermenkephalin |
| J66227 |
16679-58-6 |
Desmopressin |
| J66471 |
104360-70-5 |
Diazepam-Binding Inhibitor Fragment, human |
| J66553 |
|
Dynorphin A (1-12), porcine |
| J66598 |
117680-39-4 |
Egg Laying Hormone, Aplysia |
| J66269 |
122299-11-0 |
Eglin c (41-49) |
| J66363 |
|
Elastase Substrate IV, Colorimetric |
| J66874 |
|
Elcatonin |
| J66600 |
|
Endokinin C, human |
| J66450 |
|
Endokinin D, human |
| J66775 |
189388-22-5 |
Endomorphin-1 |
| J66953 |
141801-26-5 |
Endomorphin-2 |
| J66469 |
|
Endonuclease Antigenic Site |
| J66594 |
123562-20-9 |
Endothelin-2, human |
| J66107 |
|
Endothelin-1 (1-15) amide, human |
| J66915 |
|
Endothelin-1 (1-15), human |
| J66977 |
117399-94-7 |
Endothelin-1, human |
| J66312 |
117399-93-6 |
Endothelin-3, human |
| J66511 |
121204-87-3 |
[Ala113111115] Endothelin-1, human |
| J66758 |
|
[D-Val22, Phe33] Big Endothelin-1 (16-38), human |
| J66801 |
60117-24-0 |
Leu-Enkephalin, amide |
| J66472 |
100929-67-7 |
Met-Enkephalin, amide |
| J66199 |
117830-79-2 |
Enterostatin, human |
| J66038 |
|
Enterostatin, pig, rat |
| J66230 |
|
Erythromycin Resistance Peptide |
| J66126 |
133514-43-9 |
Exendin (9-39) |
| J66793 |
130357-25-4 |
Exendin 3 |
| J66726 |
141758-74-9 |
Exendin 4 |
| J66308 |
|
Exendin 4 (3-39) |
| J66328 |
|
Fibrinogen beta-chain (24-42) |
| J66069 |
80755-86-8 |
Fibrinogen Related Peptide |
| J66147 |
25422-31-5 |
Fibrinopeptide A, human |
| J66812 |
|
Fibrinopeptide B, human |
| J66606 |
136466-51-8 |
Fibronectin CS1 Peptide |
| J66903 |
119977-20-7 |
Fibronectin-Binding Protein |
| J66233 |
98495-35-3 |
FMRF-Like Peptide, snail, Helix aspersa |
| J66022 |
143868-20-6 |
Galanin (1-13) |
| J66716 |
125118-77-6 |
Galanin (1-16), porcine, rat |
| J66796 |
367518-31-8 |
Galanin (2-11) |
| J66251 |
|
Galanin, human |
| J66770 |
88813-36-9 |
Galanin, porcine |
| J66734 |
114547-31-8 |
Galanin, rat |
| J66575 |
138579-66-5 |
Galantide |
| J66667 |
100040-31-1 |
Gastric Inhibitory Peptide, human |
| J66401 |
11063-17-5 |
Gastric Inhibitory Peptide, porcine |
| J66088 |
134846-93-8 |
Gastric Inhibitory Peptide (1-30), porcine |
| J66510 |
81123-06-0 |
Gastrin I, rat |
| J66454 |
|
Gastrin Releasing Peptide (1-16), porcine |
| J66527 |
74815-57-9 |
Gastrin Releasing Peptide, porcine |
| J66640 |
92327-84-9 |
G-A-Y |
| J66240 |
107936-65-2 |
alpha-Gliadin (43-49) |
| J66923 |
|
Glucagon Like Peptide-1 (7-36) amide, chicken, turkey |
| J66232 |
106612-94-6 |
Glucagon Like Peptide-1 (7-37) |
| J66435 |
99658-04-5 |
Glucagon Like Peptide-1 amide, human |
| J66197 |
107444-51-9 |
Glucagon-Like Peptide-1 (7-36) amide, human |
| J66108 |
87805-34-3 |
Glucagon-Like Peptide-1, human |
| J66884 |
99120-49-7 |
Glucagon-Like Peptide-2, human |
| J66351 |
105802-84-4 |
[Ala9910, Lys11912] Glycogen Synthase (1-12) |
| J66645 |
|
GSK-3beta Peptide Inhibitor |
| J66054 |
|
GSK-3beta Peptide Inhibitor, cell permeable |
| J66883 |
|
GTP-Binding Protein Fragment, G alpha |
| J66870 |
79943-68-3 |
Head Activator Neuropeptide |
| J66287 |
|
alpha-Helical Corticotropin Releasing Factor (12-41) |
| J66772 |
96118-75-1 |
alpha-Helical Corticotropin Releasing Factor (9-41) |
| J66133 |
|
Hepatitis B Virus core protein (128-140) |
| J66539 |
113944-46-0 |
HIV Envelope Protein (254-274) |
| J66338 |
172546-75-7 |
HIV Integrase Protein Inhibitor (1) |
| J66862 |
128340-47-6 |
HIV Protease Substrate IV |
| J66488 |
|
HIV Substrate |
| J66525 |
330936-69-1 |
Humanin, human |
| J66691 |
12167-74-7 |
Hydroxyapatite nanoparticles, 5-10% (w/v) aqueous colloidal dispersion, 20-50nm particles |
| J66638 |
106018-36-4 |
Hypertrehalosaemic Neuropeptide, German Cockroach (Nauphoeta Cinerea) |
| J66614 |
162558-10-3 |
Ile-Thr-Asp-Gln-Val-Pro-Phe-Ser-Val |
| J66443 |
|
Influenza A NP (366-374) |
| J66783 |
|
Influenza A NP (366-374) Strain A/PR/8/35 |
| J66181 |
141368-69-6 |
Influenza Matrix Peptide (FluM1 58-66) |
| J66495 |
135861-49-3 |
Insulin-like Growth Factor I (24-41) |
| J66731 |
82177-09-1 |
Insulin-like Growth Factor I (30-41) |
| J66479 |
123618-03-1 |
Insulin-like Growth Factor I (57-70) |
| J66925 |
103244-41-3 |
Insulin-like Growth Factor II (33-40) |
| J66090 |
|
Intermedin (rat) |
| J66760 |
|
Intermedin, human |
| J66476 |
144602-02-8 |
IRL-1038 |
| J66049 |
|
IRL-1620 |
| J66718 |
|
JKC367 |
| J66234 |
97145-43-2 |
Kallikrein Inhibitor |
| J66384 |
|
Cys-Kemptide |
| J66633 |
|
Ketolide Resistance Peptide |
| J66333 |
|
beta-Lipotropin (1-10), porcine |
| J66273 |
72189-84-5 |
beta-Lipotropin (88-91) |
| J66843 |
|
Lys-Gly-Asp-Ser |
| J66545 |
128315-56-0 |
Melanin Concentrating Hormone, rat |
| J66264 |
87218-84-6 |
Melanin Concentrating Hormone, salmon |
| J66016 |
111682-13-4 |
N-Methoxysuccinyl-Ala-Ala-Pro-Ala-choloromethyl ketone |
| J66859 |
|
N-Methoxysuccinyl-Ala-Ala-Pro-Val-choloromethyl ketone |
| J66790 |
|
MMP-8 Substrate, fluorogenic |
| J66990 |
85490-53-5 |
Motilin, canine |
| J66400 |
52906-92-0 |
Motilin, human, porcine |
| J66051 |
106128-98-7 |
Myelin Basic Protein (1-11), human |
| J66849 |
|
[Ala4] Myelin Basic Protein (1-11) |
| J66557 |
163913-87-9 |
Myelin Oligodendrocyte Glycoprotein Peptide (35-55), rat, mouse |
| J66817 |
86933-74-6 |
Neurokinin A |
| J66898 |
97559-35-8 |
Neurokinin A (4-10) |
| J66607 |
86933-75-7 |
Neurokinin B |
| J66848 |
122063-01-8 |
[beta-Ala8] Neurokinin A (4-10) |
| J66725 |
|
[Ala5, beta-Ala8] Neurokinin A (4-10) |
| J66959 |
|
Neuromedin (U8), porcine |
| J66286 |
87096-84-2 |
Neuromedin B |
| J66625 |
843782-19-4 |
Neuromedin S, rat |
| J66682 |
117505-80-3 |
Neuromedin U, rat |
| J66509 |
99566-27-5 |
Neuropeptide FF |
| J66515 |
96827-05-3 |
Neuropeptide K, porcine |
| J66262 |
412938-67-1 |
Neuropeptide S, human |
| J66563 |
|
Neuropeptide S, mouse |
| J66112 |
383415-79-0 |
Neuropeptide W-23, human |
| J66797 |
90880-35-6 |
Neuropeptide Y, human |
| J66933 |
83589-17-7 |
Neuropeptide Y, porcine |
| J66612 |
122341-40-6 |
Neuropeptide Y (13-36), human |
| J66694 |
102961-52-4 |
Neuropeptide Y (2-36), amide, porcine |
| J66196 |
123139-39-9 |
Neuropeptide Y (2-36), human, rat |
| J66381 |
150138-78-6 |
Neuropeptide Y (3-36), human |
| J66220 |
|
Neuropeptide Y-Lys(biotin), human, rat |
| J66372 |
|
[D-Trp34] Neuropeptide Y, human |
| J66064 |
163887-48-7 |
[D-Tyr27736, D-Thr32] Neuropeptide Y (27-36), rat |
| J66243 |
39379-15-2 |
Neurotensin, guinea pig |
| J66433 |
60482-96-4 |
Neurotensin (9-13) |
| J66142 |
61445-54-3 |
[Gln4] Neurotensin |
| J66245 |
100929-52-0 |
[D-Trp11] Neurotensin |
| J66119 |
64088-62-6 |
[D-Tyr11] Neurotensin |
| J66033 |
170713-75-4 |
Nociceptin |
| J66140 |
|
Octaneuropeptide |
| J66339 |
74870-06-7 |
Oxyntomodulin |
| J66152 |
|
P34cdc2 Kinase Fragment |
| J66951 |
|
P55-TNFR |
| J66617 |
|
P75-TNFR |
| J66752 |
127317-03-7 |
PACAP (1-27), human, ovine, rat |
| J66444 |
137061-48-4 |
PACAP (1-38), human, ovine, rat |
| J66872 |
136134-68-4 |
PACAP (6-27), human, ovine, rat |
| J66342 |
143748-18-9 |
PACAP (6-38), human, ovine, rat |
| J66212 |
|
PACAP-38, amide, frog |
| J66104 |
|
PACAP-Related Peptide, human |
| J66839 |
132769-35-8 |
PACAP-Related Peptide (1-29), rat |
| J66504 |
106507-61-3 |
Pancreastatin (33-49), porcine |
| J66039 |
106477-83-2 |
Pancreastatin, porcine |
| J66317 |
81306-64-1 |
Parathyroid Hormone (13-34), human |
| J66200 |
12583-68-5 |
Parathyroid Hormone (1-34), bovine |
| J66180 |
52232-67-4 |
Parathyroid Hormone (1-34), human |
| J66330 |
98614-76-7 |
Parathyroid Hormone (1-34), rat |
| J66409 |
|
Parathyroid Hormone (1-34)-Lys(Biotin), human |
| J66417 |
104218-12-4 |
Parathyroid Hormone (1-38), human |
| J66449 |
85568-24-7 |
Parathyroid Hormone (1-44), human |
| J66777 |
51257-86-4 |
Parathyroid Hormone (3-34), bovine |
| J66773 |
79804-72-1 |
Parathyroid Hormone (39-68), human |
| J66350 |
90880-43-6 |
Parathyroid Hormone (39-84), human |
| J66604 |
64421-69-8 |
Parathyroid Hormone (44-68), human |
| J66154 |
89439-30-5 |
Parathyroid Hormone (53-84), human |
| J66106 |
|
Parathyroid Hormone (69-84), human |
| J66621 |
213533-86-9 |
Parathyroid Hormone (70-84), human |
| J66098 |
138949-73-2 |
Parathyroid Hormone Related Peptide (107-111) |
| J66559 |
|
[Asn8, Leu18] Parathyroid Hormone (1-34), human |
| J66786 |
105267-88-7 |
[Nle8821, Tyr34] Parathyroid Hormone (1-34), amide, rat |
| J66345 |
|
[Tyr63] Parathyroid Hormone (63-84), human |
| J66392 |
86292-93-5 |
[Tyr34] Parathyroid Hormone (7-34), amide, bovine |
| J66887 |
|
Biotin-Parathyroid Hormone (1-34), human |
| J66019 |
104180-33-8 |
Phe-Leu-Glu-Glu-Val |
| J66371 |
122018-58-0 |
PLP (139-151) |
| J66087 |
9003-11-6 |
Poloxamer 188 |
| J66641 |
109796-64-7 |
Prepro-Thyrotropin-Releasing Hormone (53-74) |
| J66910 |
123025-94-5 |
Prepro-VIP/PHM (111-122) |
| J66027 |
35748-51-7 |
Pressinoic Acid |
| J66768 |
11097-48-6 |
Proinsulin C-Peptide (55-89), human |
| J66395 |
215510-06-8 |
Prolactin Releasing Peptide (1-31), rat |
| J66882 |
222988-10-5 |
Prolactin-Releasing Peptide (12-31), rat |
| J66426 |
113731-96-7 |
Protein Kinase C (19-36) |
| J66928 |
50410-01-0 |
Renin Inhibitor Peptide |
| J66014 |
|
Renin Substrate 1 |
| J66671 |
110200-37-8 |
Renin Substrate Tetradecapeptide, rat |
| J66754 |
|
Rhodamine 110 bis(Z-L-isoleucyl-L-prolyl-L-arginine amide) dihydrochloride |
| J66124 |
|
Rhodamine 110 bis(succinoyl-L-alanyl-L-alanyl-L-prolyl-L-phenylalanyl amide) |
| J66921 |
352017-71-1 |
Selective Protease-Activated Receptor 4 (PAR4) Agonist |
| J66656 |
63958-90-7 |
Serum Thymic Factor |
| J66168 |
38916-34-6 |
Somatostatin 14 |
| J66274 |
73032-94-7 |
Somatostatin 28 |
| J66730 |
81286-16-0 |
Somatostatin 28 (1-12) |
| J66261 |
79243-10-0 |
Somatostatin 28 (1-14) |
| J66747 |
|
Somatostatin Tumor Inhibiting Analog |
| J66215 |
57468-17-4 |
Substance P (1-9) |
| J66922 |
53749-61-4 |
Substance P (2-11) |
| J66130 |
51165-09-4 |
Substance P (5-11) |
| J66769 |
51165-05-0 |
Substance P (7-11) |
| J66030 |
|
Substance P-Gly-Lys-Arg |
| J66831 |
76260-78-1 |
Substance P, methyl ester |
| J66954 |
|
Substance P, reversed sequence |
| J66983 |
141685-53-2 |
Thrombin Receptor Activator for Peptide 5 |
| J66526 |
141136-83-6 |
Thrombin Receptor Activator for Peptide 6 |
| J66634 |
85465-82-3 |
Thymopoietin II (32-34) |
| J66664 |
85466-18-8 |
Thymopoietin II (32-35) |
| J66498 |
56795-64-3 |
Thymopoietin II Peptide Fragment |
| J66292 |
|
Tumor Necrosis Factor- alpha (10-36), human |
| J66824 |
|
Tumor Necrosis Factor- alpha (31-45), human |
| J66980 |
|
Tumor Necrosis Factor- alpha (46-65), human |
| J66246 |
|
Tumor Necrosis Factor- alpha (71-82), human |
| J66267 |
|
Tumor Necrosis Factor- alpha (78-96), human |
| J66690 |
176591-49-4 |
Urocortin, human |
| J66297 |
171543-83-2 |
Urocortin, rat |
| J66900 |
398001-88-2 |
Urocortin II, human |
| J66906 |
330648-32-3 |
Urocortin II, mouse |
| J66924 |
|
Urocortin III, human |
| J66478 |
357952-10-4 |
Urocortin III, mouse |
| J66579 |
|
Urocortin III, mouse, free acid |
| J66939 |
9047-55-6 |
Urotensin II, goby |
| J66618 |
251293-28-4 |
Urotensin II, human |
| J66361 |
|
Z-Val-Ala-Asp(OMe)-fluoromethyl ketone |
| J66362 |
|
Val-Glu-Pro-Ile-Pro-Tyr |
| J66099 |
69856-17-3 |
Vasoactive Intestinal Peptide (10-28), human, porcine, rat, ovine |
| J66678 |
|
Vasoactive Intestinal Peptide (11-28), human, porcine, rat, ovine |
| J66201 |
|
[Lys1, Pro225, Arg324, Tyr6] Vasoactive Intestinal Peptide, human, porcine, rat, ovine |
| J66794 |
125093-93-8 |
[Lys1, Pro225, Arg324, Tyr6] Vasoactive Intestinal Peptide, human, porcine, rat |
| J66322 |
102805-45-8 |
[(4Cl)D-Phe6, Leu17] Vasoactive Intestinal Peptide |
| J64856 |
|
Hybridoma Cell Growth Supplement |
| J65182 |
|
Lipoprotein Deficient Serum, bovine |
| J65516 |
|
Lipoprotein Deficient Serum, human |
| J64483 |
|
Platelet-poor Plasma Derived Serum, bovine |
| J64856 |
|
Hybridoma Cell Growth Supplement |
| J65182 |
|
Lipoprotein Deficient Serum, bovine |
| J65516 |
|
Lipoprotein Deficient Serum, human |
| J64483 |
|
Platelet-poor Plasma Derived Serum, bovine |
| |
| |
| 02 2013 |
| |
| Product No. |
CAS |
Description |
| H35471 |
81885-67-8 |
2-Acetyl-7-amino-1,2,3,4-tetrahydroisoquinoline, 95% |
| H37509 |
141700-75-6 |
2,5-Bis(4-pyridyl)furan, 97% |
| H37485 |
52469-20-2 |
1,4-Bis(4-pyridylmethyl)benzene, 97% |
| H37979 |
67400-25-3 |
3-Bromo-5-nitro-1H-indazole, 95% |
| H36911 |
25028-32-4 |
Ethyl 2-acetylisonicotinate, 96% |
| 47050 |
19513-05-4 |
Manganese(III) acetate dihydrate, 97% |
| H61795 |
279262-11-2 |
4-(Methoxymethyl)benzeneboronic acid, 97% |
| H36325 |
|
Methyl 7-bromo-3-chloro-4-fluorobenzo[b]thiophene-2-carboxylate, 97% |
| 47010 |
1310-58-3 |
Potassium hydroxide, 45% w/v aq. soln. |
| H62803 |
19455-23-3 |
Potassium trimethylacetate, 95% |
| H37636 |
7511-49-1 |
1,3,5-Tris(4-bromophenyl)benzene, 97% |
| H36052 |
42333-76-6 |
2,4,6-Tris(3-pyridyl)-1,3,5-triazine, 97% |
| 47091 |
7440-57-5 |
Gold sputtering target, 57.0mm (2.2in) dia x 0.3mm (0.012in) thick, 99.99% (metals basis) |
| |
| |
| 01 2013 |
| |
| Product No. |
CAS |
Description |
| H37257 |
869557-43-7 |
2-Amino-3-bromo-5-fluoropyridine, 97% |
| H61077 |
98434-22-1 |
6-Bromo-2H-1,4-benzothiazin-3(4H)-one, 97% |
| H61082 |
321436-06-0 |
7-Bromo-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H61089 |
187604-75-7 |
6-Bromo-3,4-dihydro-2H-1,4-benzothiazine, 97% |
| H61021 |
193414-60-7 |
7-Bromo-3,4-dihydro-2H-1,4-benzothiazine, 97% |
| H61070 |
105655-01-4 |
6-Bromo-3,4-dihydro-2H-1,4-benzoxazine, 97% |
| H61071 |
105679-22-9 |
7-Bromo-3,4-dihydro-2H-1,4-benzoxazine, 97% |
| H37775 |
40598-94-5 |
3-Bromo-1H-indazole, 97% |
| H36695 |
70315-68-3 |
3-Bromo-6-nitro-1H-indazole, 97% |
| H61095 |
20751-75-1 |
4-(2-Chloroacetyl)-2H-1,4-benzothiazine, 97% |
| H61022 |
68321-41-5 |
4-(2-Chloroacetyl)-2H-1,4-benzothiazin-3(4H)-one, 97% |
| H61023 |
22178-82-1 |
4-(2-Chloroacetyl)-2H-1,4-benzoxazine, 97% |
| H61080 |
90619-26-4 |
4-(2-Chloroacetyl)-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H61010 |
591221-63-5 |
4-(2-Chloroacetyl)-2,2-dimethyl-2H-1,4-benzothiazine, 97% |
| H61011 |
1202773-87-2 |
4-(2-Chloroacetyl)-6-nitro-2H-1,4-benzothiazine, 97% |
| H61088 |
1202773-08-7 |
4-(2-Chloroacetyl)-7-nitro-2H-1,4-benzothiazine, 97% |
| H61019 |
128627-29-2 |
4-(2-Chloroacetyl)-6-nitro-2H-1,4-benzoxazine, 97% |
| H61056 |
|
4-(2-Chloroacetyl)-7-nitro-2H-1,4-benzoxazine, 97% |
| H55395 |
26305-75-9 |
Chlorotris(triphenylphosphine)cobalt(I), 97% |
| H36058 |
|
4-(1,4-Cyclohexadien-1-yl)-1-butanol, 97%, stab. with 0.1% BHT |
| H55923 |
19797-32-1 |
3,5-Dichlorobenzenesulfonamide, 97% |
| H55437 |
13656-60-5 |
2,4-Difluorobenzenesulfonamide, 96% |
| H61045 |
3080-99-7 |
3,4-Dihydro-2H-1,4-benzothiazine, 97% |
| H36638 |
553-03-7 |
3,4-Dihydro-2-(1H)-quinolinone, 98% |
| H61081 |
90921-53-2 |
2,2-Dimethyl-2H-1,4-benzothiazin-3(4H)-one, 97% |
| H61025 |
10514-70-2 |
2,2-Dimethyl-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H61057 |
93301-19-0 |
2,2-Dimethyl-3,4-dihydro-2H-1,4-benzothiazine, 97% |
| H61058 |
866089-28-3 |
2,2-Dimethyl-3,4-dihydro-2H-1,4-benzoxazine, 97% |
| H61008 |
265994-70-5 |
2,2-Dimethyl-6-nitro-2H-1,4-benzothiazin-3(4H)-one, 97% |
| H61052 |
945969-04-0 |
2,2-Dimethyl-7-nitro-2H-1,4-benzothiazin-3(4H)-one, 97% |
| H61097 |
85160-84-5 |
2,2-Dimethyl-6-nitro-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H61062 |
85160-83-4 |
2,2-Dimethyl-7-nitro-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H61098 |
591221-28-2 |
2,2-Dimethyl-6-nitro-3,4-dihydro-2H-1,4-benzothiazine, 97% |
| H61094 |
|
2,2-Dimethyl-7-nitro-3,4-dihydro-2H-1,4-benzothiazine, 97% |
| H61026 |
136545-11-4 |
2,2-Dimethyl-6-nitro-3,4-dihydro-2H-1,4-benzoxazine, 97% |
| H61063 |
144293-76-5 |
2,2-Dimethyl-7-nitro-3,4-dihydro-2H-1,4-benzoxazine, 97% |
| H35300 |
1000-86-8 |
2,4-Dimethyl-1,3-pentadiene, 98% |
| H55411 |
94-32-6 |
Ethyl 4-(n-butylamino)benzoate, 98% |
| H61092 |
103361-67-7 |
7-Fluoro-6-nitro-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H61065 |
122138-83-4 |
7-Fluoro-6-nitro-3,4-dihydro-2H-1,4-benzoxazine, 97% |
| H37465 |
34091-51-5 |
5-Iodo-1-methyl-1H-pyrazole, 97% |
| H33090 |
|
(4-Methoxy-6-methyl-2-pyrimidinyl)thiourea, 97+% |
| H61012 |
7028-57-1 |
2-Methyl-2H-1,4-benzothiazin-3(4H)-one, 97% |
| H61075 |
21744-83-2 |
2-Methyl-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H37805 |
|
Methyl 3-chloro-4-fluorobenzo[b]thiophene-2-carboxylate, 98% |
| H36401 |
85992-30-9 |
Methyl 1-chloronaphtho[2,1-b]thiophene-2-carboxylate, 96% |
| H36992 |
|
Methyl 3,4-dichlorobenzo[b]thiophene-2-carboxylate, 97% |
| H61005 |
58960-00-2 |
2-Methyl-3,4-dihydro-2H-1,4-benzothiazine, 97% |
| H61002 |
58960-13-7 |
2-Methyl-3,4-dihydro-2H-1,4-benzoxazine, 97% |
| H36130 |
25016-17-5 |
Methyl 5-methyl[1H]pyrazole-3-carboxylate, 96% |
| H61004 |
1368473-55-5 |
2-Methyl-6-nitro-2H-1,4-benzothiazin-3(4H)-one, 97% |
| H61030 |
105807-71-4 |
2-Methyl-7-nitro-2H-1,4-benzothiazin-3(4H)-one, 97% |
| H61028 |
57463-01-1 |
2-Methyl-6-nitro-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H61018 |
85160-82-3 |
2-Methyl-7-nitro-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H61066 |
|
2-Methyl-6-nitro-3,4-dihydro-2H-1,4-benzothiazine, 97% |
| H61060 |
|
2-Methyl-7-nitro-3,4-dihydro-2H-1,4-benzothiazine, 97% |
| H61076 |
174567-34-1 |
2-Methyl-6-nitro-3,4-dihydro-2H-1,4-benzoxazine, 97% |
| H61040 |
941291-25-4 |
2-Methyl-7-nitro-3,4-dihydro-2H-1,4-benzoxazine, 97% |
| H61615 |
2003-76-1 |
N-Methyl-N-phenyl-beta-alanine ethyl ester, 99% |
| H61031 |
21762-74-3 |
6-Nitro-2H-1,4-benzothiazin-3(4H)-one, 97% |
| H61050 |
21762-75-4 |
7-Nitro-2H-1,4-benzothiazin-3(4H)-one, 97% |
| H34335 |
|
(6-Nitro-2-benzothiazolyl)thiourea, 97+% |
| H61044 |
81721-87-1 |
6-Nitro-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H61000 |
81721-86-0 |
7-Nitro-2H-1,4-benzoxazin-3(4H)-one, 97% |
| H61061 |
1193387-98-2 |
6-Nitro-3,4-dihydro-2H-1,4-benzothiazine, 97% |
| H61048 |
69373-37-1 |
7-Nitro-3,4-dihydro-2H-1,4-benzothiazine, 97% |
| H61032 |
120711-81-1 |
7-Nitro-3,4-dihydro-2H-1,4-benzoxazine, 97% |
| H33288 |
629-89-0 |
1-Octadecyne, 97+% |
| H35190 |
2993-22-8 |
3-(Pentafluorothio)aniline, 97% |
| H35096 |
7326-19-4 |
D-(+)-3-Phenyllactic acid, 98% |
| B25034 |
129789-59-9 |
(6-Phthalimidohexyl)triphenylphosphonium bromide, 94% |
| H61645 |
1144573-61-4 |
Potassium 2-methoxypyridine-5-trifluoroborate, 97% |
| H33681 |
|
2-Pyrimidinylthiourea, 97+% |
| H55309 |
77123-58-1 |
2-[(Trimethylsilyl)ethynyl]benzaldehyde, 97% |
| 47039 |
7440-57-5 |
Gold sputtering target, 19.0mm (0.75in) dia x 1.5mm (0.06in) thick, 99.99% (metals basis) |
| H36081 |
|
Spectroflux® 100B, Lithium metaborate: Lithium tetraborate, 80:20 w/w%, 100-500 micron |
| H36024 |
|
Spectroflux® 1000B, Lithium metaborate: Lithium tetraborate,80:20 w/w%, 100-500 micron |
| 47033 |
|
Viscosity standard, Specpure®, nominally 100cSt @ 40° and 16.8cSt @ 100° |
| 47081 |
|
Viscosity standard, Specpure®, nominally 120cSt @ 40° and 19.5cSt @ 100° |
| 47021 |
|
Viscosity standard, Specpure®, nominally 360cSt @ 40° and 42cSt @ 100° |
| |
| |
| 12 2012 |
| |
| Product No. |
CAS |
Description |
| 47008 |
591-08-2 |
N-Acetylthiourea, 98% |
| 46523 |
10049-07-7 |
Rhodium(III) chloride, 99.5% (metals basis), Rh 10% w/w (cont. Rh) |
| H61464 |
823-96-1 |
Trimethylboroxine, 50% w/w soln. in THF |
| 47000 |
|
Spirit level for MSB-1 |
| |
| |
|
|
Click here to view more
|
|
11 2012
|
|
10 2012
|
|
09 2012
|
|
08 2012
|
|
07 2012
|
|
06 2012
|
|
05 2012
|
|
04 2012
|
|
03 2012
|
|
02 2012
|
|
01 2012
|
|
12 2011
|
|
11 2011
|
|
10 2011
|
|
09 2011
|
|
08 2011
|
|
07 2011
|
|
06 2011
|
|
05 2011
|
|
04 2011
|
|
03 2011
|
|
02 2011
|
|
01 2011
|
